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CHAPTER I 
INTRODUCTION
In the early days of immunology, scientists recognized the ne­
cessity for a mechanism whereby the body can recognize "self" antigens 
and thus fa il to mount an immunologic response to those body constituents. 
Indeed, in his early theory of antibody formation set forth in 1901, 
Ehrlich (Ehrlich and Morgenroth, 1957) proposed a method for such self­
recognition.
Owen (1945) observed that dizygotic cattle twins, sharing the 
same placental circulation, possessed red cells of their own blood group 
as well as those of their twin. Based on this and other observations, 
Burnet and Fenner (1949) proposed that there was a period of time during 
embryonic development in which contact with immunogenic materials re­
sulted in recognition of self, whereas contact after this period of ma­
turation elicited an immune response. Soon, Billingham, Brent and 
Medawar (1953) observed that i f  bone marrow or spleen cells were trans­
ferred from one strain of mice to another at the time of birth, the re­
cipient mice would not reject skin grafts from the donor strain when 
grafted later in life . The immune anergy produced was specific, since
1
2these animals did reject skin from a third strain of mice. The condition 
in which an animal has lost its  ab ility  to respond to a specific antigen 
was called immunologic tolerance. This state is also often referred to 
as immunologic paralysis or immunologic unresponsiveness.
In it ia lly , i t  was believed that tolerance could only be produced 
in the neonatal period with liv ing, replicating cells. However, Felton 
and Ottinger (1942) had produced unresponsiveness with pneumococcal 
polysaccharide in mice, and Hanan and Oyama (1954) reported tolerance 
induction with a soluble protein antigen. Since these early investiga­
tions, tolerance has been produced in neonatal and adult animals to a 
variety of soluble antigens (Smith, 1961; Dresser and Mitchison, 1968).
Although immunity and tolerance may appear to be opposing 
events, they share at least one common feature; that is, both result 
from the interaction of antigen with immunologically competent cells.
For this reason i t  is necessary to know the sequence of cellular events 
which occur during the production of an immune response before one can 
understand the specific cellular "lesion" in immunologic unresponsive­
ness.
Cells Involved in the Immune Response 
In recent years i t  has become apparent that several cell types 
may participate in the production of a humoral immune response. Any 
attempt to completely review all of the literature on this subject would 
be impossible. However, the reader is referred to several excellent 
reviews by Abdou and Richter (1970a), Talmage, Radovich and Hemmingsen
(1970), Playfair (1971b), M iller, Basten, Sprent, and Cheers (1971), 
Schwartz, Ryder and Gottlieb (1970), Silverman (1970) and Weigle,
3Chiller, and Habicht (1972). Both in vivo and in vitro studies have 
identified the cellular components which may cooperate in order for anti­
body production to occur. Three cells have been identified thus far.
They include the macrophage and two types of lymphoid cells.
The information covered in this discussion w ill address itse lf 
only to the cellular events involved in the production of a humoral anti­
body response and w ill not attempt to discuss the multitude of cellular 
interactions which are involved in cell-mediated immunity.
The Macrophage
As early as 1882, Elie Metchnikoff observed the phenomenon of 
phagocytosis (Metchnikoff, 1907) and proposed that phagocytic cells 
played an essential role in host resistance to infection. The concept 
of the reticuloendothelial system (RES) was conceived by Aschoff (1924). 
His system was based on the ab ility  of the RES to ingest v ita l dyes and 
other particulate material. Thus, the RES was composed of a ll of the 
phagocytic cells of the body.
Several lines of investigation have shown that macrophages may 
participate in e lic iting an immune response in animals challenged with 
immunogens. Among these are studies utiliz ing blockade of RES function, 
macrophage transfer into intact animals, and macrophage function during 
in  vitro immune responses.
Sabet, Newlin and Friedman (1968) and Sabet and Friedman (1969b) 
studied the effect of blockade by colloidal carbon of the RES on the for­
mation of anti-sheep erythrocyte, antibody. I f  carbon was administered 
24-48 hours before antigenic challenge, there was marked suppression of 
the ab ility  of spleen cells to make antibody to sheep red blood cells
4(sRBC). Treatment of animals with carbon on the same day that antigen 
was administered was less effective in suppressing the immune response, 
while treatment with carbon 1-2 days after immunization had l i t t le  effect 
on the plaque forming cell response. Sabet and Friedman (1969a) reported 
that RES blockade also interfered with the production of a normal second­
ary response to sRBC in primed mice. Carbon pretreatment was most effec­
tive in suppressing the secondary response i f  given 1-2 days prior to 
antigenic challenge. In addition, i t  was discovered (Sabet and Friedman, 
1969b) that mice injected with carbon before primary stimulation with 
sRBC had normal direct (19S) plaque forming responses after a second 
antigen injection given one month later. However, these animals failed 
to respond with an indirect (7S) RFC response. Sabet and Friedman 
called this phenomenon specific immunologic "amnesia" in contrast to 
specific immunological tolerance as the carbon treated mice responded to 
secondary challenge with antibody production similar to that seen in 
primary immunization of normal mice. Since further studies (Friedman and 
Sabet, 1970) revealed that RES blockade with carbon had only a moderate 
effect on the number of stem cells capable of differentiating into anti­
body forming cells, the effects described above could not be attributed 
to direct action of carbon on the precursor of the antibody producing 
ce ll.
Other reagents which either destroy macrophages or inh ib it 
phagocytosis have likewise been found to be immunosuppresive (Panjel and 
Cayeux, 1968; Jehn, Musher and Weinstein, 1970; Bice, Gruwell and 
Salvaggio, 1972). Anti serum prepared against macrophages was reported by 
Panjel and Cayeux (1968) to suppress antibody production in v itro , while
5Jehn et a l. (1970) observed that anti-macrophage serum inhibited the 
ability of specific antigens to e lic it  in vitro blast transformation of 
lymphocytes from sensitized guinea pigs. Anti-macrophage treatment did 
not affect blast transformation by phytohemagglutinin (PHA). Carrageenan, 
a macrophage toxic substance, when given intraperitoneally resulted in 
complete suppression of an immune response to a subsequent intraperitoneal 
injection of sheep erythrocytes (Lake, Bice, Schwartz, and Salvaggio,
1971; Bice, Gruwell, and Salvaggio, 1972). I f  the red blood cells were 
administered intravenously there was no reduction of the PFC response 
to sRBC. These authors assumed that carrageenan inhibited the ab ility 
of peritoneal macrophages to process and/or transport antigen from the 
peritoneal cavity. During in vitro cultures carrageenan was immuno­
suppressive i f  given prior to or up to 6 hrs after antigen. No suppres­
sive effect occurred i f  carrageenan was added 17 hrs after antigen.
Others. (Ascheim and Raffel, 1972) reported that the immunosuppressive 
activity of carrageenan was due to its action on lymphoid cells and that 
this substance did not inhibit macrophage activity.
In 1966, Martin found that the inab ility  of newborn rabbits to 
respond immunologically to bovine serum albumin (BSA) could be a t t r i­
buted to a deficiency in the macrophage activity of the neonate. New­
born rabbits treated with BSA plus adult macrophages could mount an anti­
body response, whereas neonates which were not given adult macrophages 
were unresponsive to this antigen. A similar observation was reported by 
Braun and Lasky (1967) who observed that adult peritoneal cells which 
adhere to glass allow newborn C57BL mice to respond to sRBC. Normally 
these animals fa il to respond to this antigen until 5-10 days after
6birth. The antibody produced by the recipient mice was made by cells of 
the recipient, since irradiation of recipients prior to transfer of 
adherent cells abolished the response. These results were confirmed by 
Argyris (1968) who reported, in addition, that administration of adult 
macrophages to C3H mice before or after a three day period resulted in 
no immune response to sRBC. Argyris noted that a critica l number of 
macrophages was required to enhance the anti-sRBC response of the new­
born mouse and that high doses of macrophages were ineffective.
Gallily and Feldman (1967) and Feldman and Gallily (1967) pre­
sented evidence that two cells were required for an immune response to 
Shigella paradysenteriae. Peritoneal macrophages which had been incu­
bated in vitro with shigella antigen and injected into sublethally 
irradiated recipients elicited an agglutinating antibody response to 
shigella. Irradiated animals were unable to respond to injection of the 
antigen alone. Because lymph node cells preincubated with antigen did 
not produce this effect and because lymphocyte-free macrophages did, 
these authors excluded the possibility that the response observed in the 
recipient was produced by lymphocytes which might have been present in 
the donor peritoneal cell inoculum. I f  recipients were given a higher, 
lethal irradiation dose, no antibody production resulted from injection 
of antigen treated macrophages. Additional support for a two cell re­
quirement came from experiments which showed that lethally irradiated 
mice only produced a significant t ite r  of agglutinating antibodies i f  
they were reconstituted with normal lymphocytes and antigen-treated 
macrophages. I f  macrophages were taken from irradiated donors they were 
unable to evoke an immune response in these cell-transfer experiments.
7Because irradiation did not inhibit the ab ility  of macrophages to phago- 
cytize sRBC, i t  was postulated that irradiation had interfered with some 
step of antigen processing within the macrophage.
Gershon and Feldman (1968) confirmed the work of Gallily and 
Feldman using Shigella paradysenteriae; however,when they tried to sub­
stitute an erythrocyte antigen, they were unable to reconstitute sub­
lethally irradiated recipients with antigen-treated macrophages. Because 
these authors had observed that thymus explants added to spleen organ 
cultures of irradiated animals previously inoculated with macrophages 
and antigen in vitro would cause a resultant antibody response, they 
pointed out that the sRBC response may require a third cell type which 
could be supplied by the thymus.
Transfer of sRBC containing macrophages (Argyris, 1967) or 
macrophages containing formalin-killed pneumococci or pneumococcal capsu­
lar polysaccharide (Argyris and Askonas, 1968) to normal syngeneic re­
cipients was followed by an iimune response to those antigens. No anti­
body was produced in recipients which had been lethally irradiated, 
suggesting that cells of the irradiated host were the actual antibody 
producers.
Pribnow and Silverman (1967) found that rabbit peritoneal macro­
phages (PEC),when sensitized in vitro to bovine gamma globulin (BGG), 
would provoke an antibody response to that antigen when transferred to 
normal recipients. I f  the antigen-sensitized peritoneal cells were 
given to irradiated recipients,no antibody was produced unless normal 
lymphoid cells were transferred at the same time as peritoneal cells.
The function of the peritoneal cell was sensitive to irradiation,as PEC
8from irradiated donors treated in vitro with antigen were ineffective in 
combination with normal lymphoid cells in evoking an immune response to 
BGG. The authors suggested, therefore, that inhibition of macrophage 
function was the in itia l radiosensitive phase of the immune response.
Using Maia squinado hemocyanin (MSH) as antigen, Unanue and 
Askonas (1968a) found that antigen associated with macrophages was more 
effective in priming animals for a subsequent secondary response than 
was free antigen. Macrophage-associated MSH produced a secondary re­
sponse in irradiated recipients provided that normal lymphoid cells were 
also administered. Irradiation of the macrophage donors, however, did 
not result in a lowering of the immunogenicity of the macrophage- 
associated hemocyanin.
Several protein antigens (BSA, human serum albumin, lysozyme 
and ovalbumin) were compared for their immunogenicity in free form or 
associated with macrophages by Mitchison (1969a). These studies showed 
that macrophages enhanced the immunogenic properties of these protein 
antigens and that irradiation of peritoneal cell donors before antigen 
administration abolished the enhancing properties of the macrophage.
I t  is apparent from the above reports that studies of the 
radiationsensitivity of macrophages are conflicting (Mitchison, 1969a; 
Unanue and Askonas, 1968a; Roseman, 1969; Pribnow and Silverman, 1967). 
Histologic studies (Brecher, Endicott, Gump and Brawner, 1948) and ex­
periments showing that whole body irradiation does not influence removal 
of particulate material from the blood stream (Benacerraf et a l. 1959; 
DiLuzio, 1955) indicated that this cell was relatively resistant to 
irradiation. However, in other experiments irradiation of macrophages
9altered their bactericidal activity and their ability to digest foreign 
red blood cells (Donaldson et a l. 1956). Kolisch and Mitchison (1968) 
reported that irradiated macrophages ingested BSA as well as normal cells 
but that the irradiated cells did not retain antigen as well as their 
normal counterparts. All of these facts suggested that macrophages may 
develop what has been called "radiation indigestion" (Schwartz, Ryder, 
and Gottlieb, 1970). Differences in the sensitivity of macrophages to 
irradiation may also reflect differences in the handling of the various 
antigens used in these studies. I t  is possible that macrophages play no 
role in the immune response to some antigens, or that the immunogenic 
function of macrophages with regard to different antigens varies. For 
example, hemocyanin may not require the radiosensitive function (Unanue, 
1969) which is necessary for macrophages to render protein antigens 
immunogenic (Kolisch and Mitchison, 1968).
Frisch and Wilson (1969) and Many and Schwartz (1970) discovered 
that mice which were suppressed with cyclophosphamide did not respond to 
sRBC, whether or not that antigen was associated with macrophages. 
Macrophages of cyclophosphamide-treated donors could ingest erythrocytes 
and trigger antibody synthesis to the red cell when injected into normal 
mice, therefore cyclophosphamide did not suppress the function of the 
macrophage. On the other hand, cycloleucine treated mice could respond 
with antibody production when challenged with antigen associated with 
normal macrophages (Frisch and Wilson, 1969). Macrophages from cyclo­
leucine treated animals were immunologically inert, even though they 
could phagocytize antigen as well as normal macrophages. Such experi­
ments suggested that at least two cells were required for an immune
10
response to erythrocytes, and that engulfment of antigen £er S£ by macro­
phages did not insure that macrophage function was intact.
Mi shell and Dutton (1966, 1967) developed an in vitro system 
for immunizing spleen cells with erythrocyte antigens. Their procedure 
involved the culture of dissociated spleen cells with foreign erythro­
cytes for four days. At the end of the incubation period spleen cells 
producing antibody were enumerated by the Jerne plaque assay for direct 
plaque forming cells (PFC) to the red cell antigen. This technique has 
allowed these and other investigators to analyze exactly what cell types 
are required for the in vitro immune response.
At least two cell types were found by Hosier (1967) to be 
necessary for the in vitro response of spleen cells to erythrocyte anti­
gens. These cells were separated according to their ab ility  to adhere 
to glass. Adherent and non-adherent cells alone were unable to respond 
to antigenic stimulation, but i f  they were put together in culture with 
antigen an immune response ensued. Hosier reported that incubation of 
adherent cells with antigen for 30 min,followed by thorough washing of 
the cells,endowed these cells with the ab ility  to induce antibody pro­
duction to sRBC in the non-adherent cell population. This work was ex­
tended by Hosier and Coppelson (1968) who cultured serial dilutions of 
one cell population in the presence of a constant, large number of the 
other population of cells. The log of the PFC response was plotted 
against the log of the diluted cell population present in the culture. 
When adherent cells were diluted the slope of the regression line was 
1.0, whereas dilution of the non-adherent population gave a regression 
line with a slope of 1.9. When diluted, unseparated spleen cells were
n
used the slope of the line was 2.6. Hosier and Coppelson concluded from 
these data that three cells were involved in the in vitro immune response: 
an adherent cell and two non-adherent cells. Hosier (1969) found, in 
addition, that spleen cells formed clusters while undergoing an immune 
response to sRBC in v itro . These clusters contained most of the anti­
body producing cells in the culture and disruption of the clusters in ­
hibited the appearance of PFC in the cultures. Specific reaggregation 
of clusters occurred, which could be specifically inhibited by adding 
antibody to sRBC to the culture. Addition of two types of erythrocytes 
(sheep and burro) to the cultures resulted in individual clusters pro­
ducing antibody to only one of the two RBC types. Many of the cell 
clusters contained monocytes as well as lymphocytes.
Pierce and Benacerraf (1969) and Pierce (1969, 1970) confirmed 
Hosier's discovery that cell clusters were required for in vitro anti- 
body production. In their experiments clusters appeared within six hrs 
of the beginning of culture i f  the cultures were incubated on a rocking 
platform, and the clusters remained for the duration of the incubation 
period (4 days). I f  cultures were incubated without rocking, fewer 
clusters and fewer PFC resulted. Adherent, phagocytic cells were found 
to be responsible for cluster formation. Anti-sRBC antibody specifically 
suppressed the PFC response against sheep erythrocytes i f  added at the 
beginning of culture or 24 hrs later, indicating that during this 24 hr 
time period the culture system was antigen dependent. Various other al­
terations in the culture conditions allowed the identification of two 
steps necessary for the in vitro antibody response. The f ir s t  step de­
pended upon the participation of macrophages and cluster formation, and
12
required 24 hrs to go to completion. The second step did not depend on 
presence of macrophages. I t ,  too, was of 24 hrs duration and probably 
signaled the in itia tion of cell transformation in the non-adherent lympho­
cyte population. After the f irs t  48 hrs activated lymphocytes could de­
velop into plaque forming cells independently, without antigen, macro­
phages or cell clusters.
Hartman and coworkers (1970) and Mishell, Dutton and Raidt (1970) 
found that spleen cell populations could be separated on discontinuous 
albumin gradients due to differences in their density. By use of this 
technique, they obtained four bands of cells which they called A, B, C, 
and D. When cells from band A or D were cultured alone with sheep red 
blood cells, no antibody production occurred. However, small numbers of 
cells from the A band added to the 0 band cultures allowed an anti- 
erythrocyte response. They further analyzed the in vitro antibody re­
sponse in regard to the requirement for adherent and non-adherent cells.
As had been reported by Nosier, they found that both cell types were 
required. Utilization of anti-H-2 serum and donors who differed at the 
H-2 histocompatability locus allowed the identification of the precursor 
of the antibody forming cell as a member of the non-adherent spleen cell 
population. I t  was reported by Dutton, McCarthy, Mishell and Raidt (1970) 
that A band and adherent cells were equally effective in restoring the 
response of D band cells, and that cell free supernates of these cells 
could also restore the ab ility  of non-adherent or D band lymphocytes to 
respond to antigenic stimulations. This was true whether or not the cells 
were preincubated with antigen. The phenomenon could not be attributed 
positively to macrophage function, since A band cells were markedly
13
depleted of macrophages, Hoffman and Dutton (1971) found that the factor 
in supernates of macrophages could be absorbed by red cell antigens but 
that the absorption was not antigen specific. Additionally, they ob­
served that treatment of erythrocyte antigens with macrophage supernates 
rendered these cells capable of stimulating non-adherent cells in the 
absence of attached cells or attached cell supernates. The nature of 
the substance in macrophages culture supernatant fluids was not deter­
mined. I t  appeared unlikely that i t  was antibody as i t  was not antigen 
specific and supernate-treated RBC were not agglutinated by anti-IgG or 
anti-kappa chain antisera.
Alter and Bach (1970) and Bach et a l. (1970),in studies of the 
requirement for adherent cells in the production of a blastogénie re­
sponse by antigen stimulated lymphocytes, also found that supernatant 
fluids of macrophage cultures would substitute for the cells themselves. 
Due to these observations Dutton and colleagues (1970) warned that syner­
gistic effects may be due to an increase in the number of precursors 
stimulated or they could reflect an increase in the number of antibody 
forming cells derived from each precursor cell. Such might be the case 
i f  a nutritional requirement were supplied.
The ab ility  of a 0.83 per cent ammonium chloride solution to 
lyse erythrocytes without damaging nucleated spleen cells was used by 
Leserman, Roseman, and Hosier (1971) to study the antigen dependent 
phase of the in vitro immune response. These authors reported that 
treatment of RBC stimulated spleen cell cultures with ammonium chloride 
one day after the beginning of culture abolished any PFC response ob­
served after four additional days of incubation. Addition of more RBC
• 14
after the ammonium chloride treatment restored the PFC response. Ammonium 
chloride treatment on the third day of culture did not reduce the PFC re­
sponse. Suspensions of adherent cells were incubated for 1 to 3 days 
with red cells and then treated with ammonium chloride. After washing of 
the macrophages non-adherent cells were added. No PFC resulted after 
five additional days of incubation unless the red cell antigen was re­
placed. These results demonstrated that although adherent cells were re­
quired for in vitro antibody production, they were unable to protect 
antigen from lysis by ammonium chloride.
Another approach to studying the requirement for macrophages in 
the in vitro immune response was taken by Sabet and Friedman (1970).
They observed that addition of carbon particles to spleen cell cultures 
resulted in a suppression of the primary immune response to sheep erythro­
cytes. I f  carbon treatment was delayed for 48 hrs after the in itiation 
of culture, less immunosuppression occurred. Treatment of donors of 
spleen cells with carbon in vivo 1 to 2 days prior to sacrifice also pro­
duced a subsequent suppression of the in vitro immune response.
Hoffman (1970) reported that the presence of peritoneal macro­
phages enhanced the PFC response of spleen cells studied by the Mishell 
and Dutton culture technique. He found that a critica l ratio of PEC to 
spleen cells was required for maximum stimulation and that too many PEC 
would suppress the in vitro immune response. Peritoneal exuate cells 
could restore the ab ility  of the non-adherent spleen cell population to 
respond to antigenic challenge.
While adherent cells appeared to be necessary for the in vitro 
response to erythrocyte antigens, Diener, Shortman and Russell (1970)
15
and Shortman and Palmer (1971) observed that macrophages were not neces­
sary for an immune response to a polymerized form of Salmonella adelaide 
flagellin (POL). In fact, addition of peritoneal exudate cells to spleen 
cell cultures caused a decrease in the immune response to that antigen. 
Addition of anti-macrophage serum blocked the in vitro anti-sRBC response 
but did not affect the anti-POL response. Addition of PEC to macrophage- 
free spleen cells restored the responsiveness of the lymphocytes to sRBC. 
I t  appeared that macrophages released some ncnsedimentable antigenic 
material from erythrocytes, due to the finding that culture supernates 
obtained from incubation of macrophages with erythrocytes could in itia te  
immune responses in macrophage-free cultures of lymphocytes.
That the importance of the macrophage may vary with the antigen 
used has been pointed out by Unanue and Askonas (1967, 1968a, 1968b) and 
Unanue (1969). These workers have observed a necessity for macrophage 
participation in the immune response to Maia squinado hemocyanin (MSH), 
while macrophages were not necessary to e l ic it  an immune reaction against 
the hemocyanin obtained from keyhole limpet (KLH). Aaskov and Halliday
(1971) reported that in vitro investigations had revealed that macro­
phages were required for an immune response to pneumococcal polysaccha­
ride. This was in disagreement with the results obtained indirectly 
through in vivo investigation (Howard and Siskind, 1969).
Conflicting reports on the role of the macrophage in the sec­
ondary immune response have come from in vitro studies. Pierce (1969) 
found that macrophages were not necessary to e lic it  an immune response 
in macrophage-poor cultures of spleen cells from mice primed with 
Iieterologous erythrocytes. Nevertheless, Pierce pointed out that the
16
cultures were not entirely free of macrophages and i t  could not be said 
with absolute certainty that the few remaining phagocytes in these cul­
tures were not contributing to the immune response. Moore and Schoenberg 
(1968, 1971) reported that macrophages were not necessary for restimula­
tion of primed lymphocytes and, in fact, actually attentuated the immune 
response when present. Conversely, Sabet and Friedman (1970) found that 
the in^  vitro secondary immune response to sRBC was suppressed by treat­
ment of the cultures with carbon particles which presumably interfere 
with macrophage function. Others (Cosenza and Rowley, 1971; Cosenza, 
Leserman, and Rowley, 1971) observed a requirement for adherent cells in 
the secondary immune response.
Evidence that antigens retained by tissues are complexed to a 
small molecular weight RNA was f ir s t  reported by Garvey and Campbell 
(1957) and Campbell and Garvey (1963). They found fragments of BSA 
complexed to RNA of live^ macrophages several months after injection of 
the BSA antigen. These authors were the f ir s t  to suggest that such 
antigen-RNA complexes might be important in responsiveness to antigens. 
This idea stemmed from their observation that antigen-RNA extracts were 
more sensitive in promoting anaphylaxis than was the original antigen 
alone.
Fishman (1959, 1961) and Fishman and Adler (1963) observed that 
lymph node cells would synthesize antibody against T^  bacteriophage i f  
they were exposed to macrophages or to RNA extracts of macrophages which 
had been preincubated with the phage particle. Further investigations 
by Fishman, Hammerstrom and Bond (1963) showed that the immunogenicity 
of the RNA extracts was specific for the type of phage used in the
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macrophage sensitization step, and that the immunizing activity was sen­
sitive to ribonuclease digestion.
Friedman, Stavitsky and Solomon (1965) discovered that RNA from 
macrophages sensitized with Tg phage could e lic it  a secondary response 
when injected into mice primed with Tg. I f  the RNA preparation was 
treated with ribonuclease most, but not a ll,  of the immunogenic properties 
were lost. This observation suggested that some of the antigenic com­
ponents of the Tg phage might s t i l l  be present in the RNA preparation, 
and,indeed, Friedman and colleagues could detect such components by a 
sensitive complement fixation reaction. Hemocyanin labeled with radio­
active iodine was found in immunogenic RNA fractions obtained from mouse 
peritoneal cells which had ingested labeled antigen by Askonas and 
Rhodes (1965).
Adler, Fishman, and Dray (1966), Fishman and Adler (1967) and 
Fishman, Adler and Holub (1968) described two types of immunogenic RNA 
which could be extracted from macrophages treated with antigens. One 
of the RNA fractions was free of any demonstrable antigen and was found 
to be responsible for mediating the 19S antibody response. The other 
RNA fraction contained both RNA and associated antigen. I t  was respon­
sible for the production of the 75 antibody response. In addition, both 
the RNA and protein components of this second fraction were necessary 
for immunogenicity. Although i t  could be argued that the RNA elic iting 
the 195 response could contain antigen which was undetectable by present 
techniques, other observations made this possibility doubtful. F irst, 
these workers found that the antibody produced in response to this RNA 
fraction carried allotypic markers characteristic of the macrophage
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donor, and second, i f  actinomycin was added to the macrophage cultures 
before antigenic stimulation, the resultant RNA extracts were capable of 
evoking only a 7S response. These two observations lent support to the 
hypothesis that RNA involved in the 19$ response was newly formed by 
peritoneal exudate cells after antigenic stimulation and that i t  served 
as a messenger RNA. On the other hand, the RNA participating in the 75 
response was thought to be preformed within the phagocytic cell.
Those who claim that macrophages produce a messenger RNA which 
programs lymphocytes to produce specific antibody have yet to prove that 
this RNA does not come from lymphocytes which are known to be present in 
peritoneal exudates. Schwartz, Ryder, and Gottlieb (1970) postulated an 
alternative to the messenger hypothesis to explain the observation that 
macrophages can direct allotypic specificity. They suggested that some 
as yet undescribed transfer RNA specific for the allotypic locus might 
be present in macrophages (or lymphocytes).
Pinchuck et a l. (1968) discovered that C57BL/6 mice, which re­
spond very poorly to a synthetic polypeptide, would produce antibody 
against that polypeptide i f  i t  was associated with normal macrophages 
or RNA from normal macrophages obtained from mice, rats or rabbits. In­
cubation of RNA obtained from macrophages treated with the polypeptide 
antigen with a second antigen did not render the second antigen immuno­
genic in mice injected with the RNA-antigen mixture.
Gottlieb, Glisin and Doty (1967) found that highly immunogenic 
ribonucleoprotein complexes were formed in macrophages which had in­
gested antigen. Antigen (Tg phage) was present in an RNA fraction which 
had a unique banding density in cesium sulfate gradients, and Tg phage
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was associated with this RNA fraction only. The same RNA was present in 
both Tg-treated macrophages and macrophages incubated with a second virus. 
Both the immunogenic potential and the unique band seen in cesium sulfate 
gradients were lost after pronase digestion.
There have been some indications that new RNA synthesis results 
after macrophages ingest antigen. Halac, Rife and Renal dine (1964) ob­
served a shift in the base composition of macrophage RNA after the cells 
were incubated in vitro with bovine serum albumin. Actinomycin D treat­
ment of macrophages was shown by Bishop, Pesciotta and Abramoff (1967) 
to inhib it the production of a new 6-1 OS RNA found in anti gen-treated 
macrophages. This RNA was shown to be responsible for enhancing the 
immunogenicity of antigen. Results of Cruchaud et a l. (1970) were in 
direct disagreement with these reports. They reported that actinomycin 
D treatment of macrophages was only moderately inhibitory of the immuno­
genic potential of macrophage-associated antigen and, therefore, that 
RNA synthesis by macrophages must not be the only factor which was im­
portant in the response to macrophage-associated antigen.
The competitive hybridization experiments of Gottlieb and Straus
(1969) provided evidence that the immunogenic RNA found in macrophages 
was not specific for antigen. RNA obtained from macrophages incubated 
with R17 phage could effectively compete for binding sites on DNA with 
RNA extracted from Tg treated macrophages. Gottlieb (1969) determined 
from the small size (m.w. 22,000) of the RNA he studied, and from its 
relatively high guanine-cytosine content (58 per cent),that i t  was not 
a messenger RNA. Such a messenger would be too small to code for either 
the H or the L chain of immunoglobulins.
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A caution to studies demonstrating binding of antigens to macro­
phage RNA has been put forth by Roelants and Goodman (1969) who deter­
mined that binding of antigens to RNA was an artifact brought about by 
linking anionic groups of antigens to RNA through Mg^  ^ bridges. They 
observed that the formation of such complexes was unrelated to the potency 
of the antigen, did not depend on enzyme function, and did not require 
the synthesis of RNA after the introduction of antigen. In addition, 
there was a total absence of any relationship between immunogenicity and 
the capacity to form complexes with RNA.
Unanue and coworkers in a long series of articles have described 
experiments supporting the concept that macrophages function by carrying 
antigens on their cell membrane in high local concentration to lymphoid 
cells. These workers believe that antigen may not necessarily be 
actively "processed" by macrophages (Unanue and Askonas 1968a, 1968b; 
Unanue, Cerottini, and Bedford, 1969; Cruchaud and Unanue, 1971). 
Electronmicroscopic radioautographic studies of Unanue, Cerottini, and 
Bedford (1969) revealed localization of radiolabeled antigen in digestive 
vacuoles and on the surface of the macrophage. The material on the cell 
surface persisted up to 72 hrs without being incorporated into vacuoles. 
Membrane bound antigen was removed by treatment of the cells with trypsin 
or with EDTA. The antigenic material removed oy these treatments was 
heterogeneous but of large molecular size. Because trypsin or EDTA 
treatment abrogated the immunogenic properties of the cells, these 
workers attributed the immunizing ab ility  of antigen-macrophage complexes 
to the few molecules of antigen which were present on the surface of the 
cell (Unanue and Cerottini, 1970).
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Schmidtke and Unanue (1971a) studied the uptake of radioactively 
labeled autologous and heterologous albumins by macrophages of normal 
mice. Both mouse and human albumin were engulfed and metabolized to the 
same extent by mouse peritoneal macrophages. The amount of antigen in­
gested was dependent on its  physical form and not upon its  foreignness 
to the macrophage donor. Most of the albumin was rapidly catabolized, 
but a small proportion remained associated with the cells both intra- 
cel lu larly and on the plasma membrane. They found that the antigen on 
the cell membrane was maintained independently of the intracellular 
albumin and that this membrane-bound material was responsible for the 
immunogenic potential of the macrophage-associated albumin.
When sheep red blood cells were used as antigen, Cruchaud and
Unanue (1971) reported that antigenic material was released from macro-
125phages into the extracellular flu id and that small amounts of I-labeled 
antigen could be found on the cell surface. The cell-associated antigen 
was more immunogenic than that released into the medium. Release of
I O C
non-protein bound "" I indicated that the red cells were catabolized 
intracellularly, but i t  was also apparent that some molecules of the 
antigen escaped extensive catabolism and became associated with the cell 
membrane where they were available for recognition by lymphoid cells.
The controversey over the role of the macrophage in the induc­
tion of immunity is s t i l l  unsettled. I t  is not clear whether macrophages 
provide a specific messenger RNA for antibody synthesis; a highly un­
like ly possibility due to the fact that macrophages themselves do not 
produce antibody (Adler, Fishman and Dray, 1966). On the other hand, 
antigen may combine specifically with an RNA which is induced by contact
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with the antigen or nonspecifically with an RNA which is preformed in 
the macrophage. Such antigen-RNA complexes may then possess enhanced 
immunogenic properties. I t  was suggested by Braun (1969) that RNA alone 
may act as an activator or a repressor of lymphocytes, but that when 
antigen is complexed with the RNA, the antigen acts to guide the RNA- 
activator to the proper cell. In this regard, i t  is interesting to note 
that Campbell and Kind (1971) have recently reported that polynucleotide 
adjuvants act by stimulating the precursor of the antibody forming cell.
Lymphoid Cells
For some time immunologists have recognized that different types 
of immunity appear after exposure of an animal to foreign antigen. Dif­
ferent types of hypersensitivity were in it ia lly  described by differences 
in the time of appearance of skin test reactions upon challenge with 
antigen. Prausnitz and Kustner (1921) were successful in transferring 
immediate hypersensitivity to fish with the serum of a sensitive donor. 
Helmholtz (1909) passively transferred delayed hypersensitivity to 
tubercle bac illi with defibrinated blood of infected guinea pigs. Later, 
Chase (1945) determined that the lymphocyte was responsible for passive 
transfer of delayed-type hypersensitivities. Passive transfer experiments 
thus provided a firm foundation for the belief that there was some sort of 
compartmentalization of the immune response.
The separation of delayed-type from immediate-type immune re­
actions became more apparent upon the discovery by Coons, Leduc and 
Connally (1955) that the plasma cell was responsible for antibody forma­
tion, while the small lymphocyte was implicated in reactions of homograft 
immunity (Gowans, McGregor and Cohen, 1963) and the graft-versus-host
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reaction (Heldemann, Linscott, and Marlino, 1962).
One of the most important discoveries in the fie ld of cellular 
immunology was made by Miller (1961) who found that neonatal thymectomy 
in mice prevented development of cell-mediated immunity and some humoral 
antibody responses. Previously i t  was believed that removal of the thymus 
in adult li fe  was inconsequential. However, M iller (1965) observed a 
slow waning of immunological competence in adult animals after thymectomy. 
Immune impairment similar to that seen in neonatally thymectomized ani­
mals resulted from removal of the thymus followed by letahal irradiation 
and bone marrow reconstitution (M iller, Doak, and Cross, 1963). Because 
the thymus contained few, i f  any immunocompetent cells, as judged by its 
lowered ab ility  to induce a graft-versus-host reaction or to adoptively 
transfer antibody formation, the concept of the "central" lymphoid tissue 
arose (Playfair, 1971b). Central lymphoid tissue was defined as any 
organ which plays a critica l role in the early differentiation of cells 
toward immunological competency but which is not itse lf engaged in immune 
responses. The central lymphoid tissi-,- supply competent cells to the 
"peripheral" lymphoid tissue where these cells further differentiate and 
divide upon antigenic stimulation and where immune reactions manifest 
themselves.
Click, Chang and Japp (1956) were f ir s t  to report that the avian 
bursa of Fabricius played an essential role in the development of humoral 
immunity in that species. Further studies with chickens (Warner and 
Szenberg, 1962, 1964; Jankovic and Isvaneski, 1963) provided evidence 
that the avian thymus exerted its  influence on the development of small 
lymphocytes engaged in cellular immunity. Thus, the chicken was found
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to have two central lymphoid organs, the thymus and bursa of Fabricius.
In mammals, the organ which functions as does the bursa in fowl 
has not been identified, but i t  is speculated to be some gut-associated, 
lympho-epithelial tissue (Archer, Sutherland and Good, 1963). Experi­
mental evidence that the gut-associated lymphoid tissue of rabbits may be 
equivalent to the bursa of the chicken was provided by the work of Cooper 
and coworkers (1968).
Lymphoid cells which are influenced in their development by the 
thymus have been given the names, thymus-dependent cells, or T-cells. 
Those cells which require the bursa of Fabricius for development (as in 
the chicken) or which originate from the bone marrow of mammals have 
been named bursa-dependent cells, bone marrow-derived cells, or B-cells.
Evidence for Cellular Cooperation in the Immune Response
Evidence for a cooperative effect between thymus-derived lympho­
cytes and bone marrow-derived lymphocytes in the production of a humoral 
immune response to certain antigens, such as heterologous erythrocytes 
and serum proteins has accumulated recently (Claman and Chaperon, 1969; 
Miller and Mitchell, 1969; Miller, Basten, Sprent, and Cheers, 1971; 
and Playfair, 1971b). These investigations have included studies of 
hapten-carrier effects, consequences of neonatal thymectomy, and partic­
ipation of T-cells and B-cells during in vivo and in vitro immune re­
sponses.
The carrier effect. By definition a hapten is not immunogenic 
by its e lf but combines with antibody produced against i t  when i t  is 
coupled to a macromolecular carrier. Brownstone, Mitchison and 
Pitt-Rivers (1966) reported that optimal secondary responses to haptens
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only occurred in animals immunized with the carrier used in primary 
immunization. The protein carrier did not contribute to the binding 
energy of the hapten with antibody suggesting that anti-hapten antibody 
did not distinguish structural characteristics of the carrier molecule. 
This fact was d iff ic u lt to explain with current theories of antigen 
recognition unless one assumed that two or more cells were involved; one 
cell recognizing the haptenic determinant and others recognizing deter­
minants on the carrier molecule.
Other investigators reported that preimmunization of an animal 
with a hapten-carrier complex would increase the antibody response to 
a second carrier i f  that carrier was complexed to the original hapten.
In addition, i f  two haptenic determinants were used in such experiments, 
a better response occurred (Dixon and Maurer, 1955; Weigle 1962, 1964, 
1965a, 1965b; Linscott and Weigle, 1965; Dietrich, 1966; Plescia et a l., 
1968; Leskowitz, 1968; Rajewski, 1969). The enhancement seen with 
multiple determinants brought about the proposal that there might be a 
requirement for cellular interactions in the immune response. I f  this 
were the case each additional determinant would serve to increase the 
possibility of such cellular encounters. I t  was apparent that cells 
specific for one determinant could interact with cells recognizing 
another determinant and that such interactions would increase the re­
sponsiveness of the second cell.
In 1967, Benacerraf, Green and Paul noted a genetic defect in 
strain 13 guinea pigs which resulted in their inability to mount an 
antibody or delayed hypersensitivity response to a DNP-poly-lysine com­
plex. Normal responses to DNP occurred in these animals i f  the DNP
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hapten was coupled to a BSA carrier. A similar observation in rabbits 
was reported by Rajewsky et a l■ (1967) who observed that some rabbits 
could not make antibody against one of the two subunits of the lactic 
dehydrogenase enzyme. I f  the hybrid molecule was injected into these 
animals, antibody was produced against both subunits. Animals immuno­
logical ly  tolerant of the carrier subunit did not produce detectable 
antibody after immunization with the hybrid enzyme. Thus, antibody pro­
duction in the studies of Benacerraf et a l. and Rajewsky et a l. required 
the simultaneous recognition of both the hapten and the carrier molecules.
I t  was determined by Mitchison (1967) that the carrier and the 
hapten did not act as parts of a single determinant. He placed "spacer" 
molecules between the hapten and the carrier and found that this inser­
tion did not affect the immunogenicity of the complex.
The clearest evidence that the hapten-carrier effect is due to 
the interaction of two different cells came from cell transfer studies. 
Spleen cells from mice primed to a hapten-carrier complex were not 
effective in producing an immune response after transfer to irradiated 
recipients i f  they were challenged with the hapten on a different carrier. 
Responsiveness was restored i f  the animals were given spleen cells from 
another donor which was primed with the carrier used in the challenge.
Transfer of lymphoid cells from bovine gamma globulin (BGG) 
primed guinea pigs to DNP-ovalbumin-primed guinea pigs was reported by 
Paul and coworkers (1970) to markedly enhance the secondary anti-DNP re­
sponse of these animals when challenged with DNP-BGG. I f  the BGG primed 
cells were obtained from animals rendered immunologically unresponsive 
to BGG no enhancement of the anti-DNP response occurred.
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Hapten-carrier effects have been observed in in vitro experi- 
ments as well as in the in vivo studies reported above (Katz, Bluestein, 
Rouques, and Pierce, 1971; Segal, Globerson, and Feldman, 1971a, 1971b; 
Kunin, Shearer, Segal, Globerson and Feldman, 1971; Kettman and Dutton, 
1971; Falkoff and Kettman, 1972). These reports have also pointed to 
the need for cellular cooperation in the immune response.
Segal et a l. (1971a, 1971b) and Kunin et a l. (1971) determined 
that in vitro production of a primary response to alpha-DNP-poly-L-lysine 
was inhibited by free DNP-lysine or free poly-L-lysine, demonstrating the 
presence of specific cellular receptors for both the hapten and the 
carrier. Preimmunization of animals in vivo with carrier enhanced the 
primary response against the hapten by spleen cells in v itro . This 
effect was carrier specific. I f  vinblastine was given to the animal 
simultaneously with the carrier preimmunization, the subsequent in vitro 
response to the DNP-carrier complex was abolished. However, administra­
tion of vinblastine 24 hrs after carrier pretreatment had no effect.
These authors proposed that the carrier effect may occur due to the 
stimulation of just one cycle of DNA replication. They suggested that 
this replication cycle might be necessary for the production of more 
carrier specific receptors.
I t  was reported by Segal et a l. (1971b) that spleen cells from 
rabbit serum albumin (RSA) tolerant animals did not respond to RSA-DNP 
but did respond to hemocyanin-DNP. Pretreatment of RSA tolerant spleen 
cells with DNP-RSA three hours prior to application of alpha-DNP-poly-L- 
lysine abrogated a subsequent anti-DNP response. This provided evidence 
for the presence of functional receptors for DNP on the antibody forming
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cell in the carrier tolerant animal. Tolerance could be attributed to 
a separate cell which only responds upon contact with the carrier mole­
cule.
Kunin and coworkers (1971) studied the role of thymus-derived 
and bone marrow-derived cells in the hapten-carrier phenomenon. Anti­
body to DNP was not produced in vitro by spleen cells of lethally irrad i­
ated animals which had been reconstituted with bone marrow cells or 
thymus cells alone and then primed with carrier. I f  the irradiated 
animals were treated with RSA and T-cells 6-8 days before injection of 
bone marrow cells, the carrier effect occurred in cultured spleen cells. 
This effect was not observed when RSA and bone marrow were administered 
6-8 days before an injection of thymus cells, however. These results 
suggested that an in it ia l interaction of carrier with thymus-derived 
cells was necessary before the bone marrow cell could be stimulated to 
produce antibody.
Similar carrier effects were observed by Kettman and Dutton 
(1971) when spleen cells were immunized in vitro with TNP coupled to red 
blood cell carriers. They noted that spleen cells from carrier-primed 
animals would enhance the anti-hapten response of normal spleen cells 
when the two cell types were mixed in culture. These workers determined 
that the carrier primed cells were thymus-derived, and that once these 
cells were primed, they were resistant to irradiation (Kettman and 
Dutton, 1971; Falkoff and Kettman, 1972).
The premium effect. Cel da (1967),in studies of the secondary 
immune response to human serum albumin (HSA),discovered that the anti-HSA 
response increased disproportionately with the number of spleen cells
29
transferred to irradiated recipients. He called this phenomenon "the 
premium effect". Later, Gregory and Lajtha (1968) reported that although 
the number of hemolytic foci to sRBC increased linearly with the number 
of spleen cells transferred to irradiated animals, the RFC response in­
creased out of proportion to the size of the spleen graft. Since i t  has 
been clearly shown that the number of RFC detected in a suspension of 
immunized cells is linearly related to the number of cells plated (Jerne, 
Nordin and Henry, 1963) and that this number is not affected by the pre­
sence of unimmunized cells (Celda, 1967),synthesis and release of anti­
body is considered to be an independent function of a single cell.
Gregory and Lajtha emphasized that since the rate and number of divisions 
of RFC precursors increased with increasing chance for cellular inter­
actions, the production of RFC from their precursors could be attributed 
to a cooperative process. A similar effect was reported by Bussard and 
Lurie (1967) who observed that the total number of RFC produced in vitro 
by peritoneal cells increased disproportionately to the number of cells 
in culture.
Immune response in thymus-deprived animals. The thymus gland is 
known to be essential for the normal development and function of lymphoid 
tissue, and especially for the ontogeny of immune responses which are 
considered to be cell mediated (Miller, 1961, 1964; Miller and Osoba, 
1967). In addition to the depressive effect that neonatal thymectomy 
has on cellular immunity, this treatment has resulted in depression of 
humoral immune responses against sheep erythrocytes (Basch, 1966; 
Friedman, 1965; Humphrey, Rarrott and East, 1964; M iller, deBrough, and 
Grant, 1965), ovalbumin (Arnason, DeVaux St. Cyr, and Schaffner, 1964)
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and BSA (Arnason et a l., 1964; Taylor, 1963). Lowered responses due to 
lack of T-cells have been borne out in studies of the immune response of 
congenitally thymusless "nude" mice (Kindred, 1971; Reed and Jutila, 
1972). Responses of thymectomized mice to other antigens such as tetanus 
toxoid (Hess, Cottier, and Stonar, 1963; Hess and Stonar, 1966), pneumo­
coccal type I I I  capsular polysaccharide (Fahey, Barth and Law, 1965; 
Humphrey et a l., 1964), Salmonella flagellar antigen (Pinnas and Fitch, 
1966), fe rr it in  (Fahey et a l., 1965) and hemocyanin (Fahey et a l., 1965; 
Humphrey et a l., 1964; and Unanue, 1970) are not different from that of 
sham operated controls.
Neonatal thymectomy may severely depress but not completely 
eliminate the humoral antibody response under study. Masser, Cooper, 
and Good (1967) and Masser, Good and Cooper (1970) reported that a com­
bined treatment of neonatal thymectomy followed by irradiation (Tx-X) 
produced an even greater depression of the anti-erythrocyte response when 
animals were challenged in adult l i fe  as compared to animals who were 
only thymectomized as neonates. On the other hand, Tx-X animals re­
sponded as did normal or sham thymectomized animals upon challenge with 
Brucella abortus or Salmonella typhosa.
The effect of neonatal thymectomy on the immune response has 
been overcome by increasing antigen doses one hundred fold (Sinclair, 
1967; Sinclair and E llio tt, 1968; Lemmel, Cooper and Good, 1971; Aird,
1971). These data implied that thymus-derived cells were not obligatory 
for the immune responses which were depressed in thymus-deprived animals, 
but that these cells merely served to amplify the response. On the other 
hand, Playfair (1971b) suggested that the delayed immune responses
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resulting from increased antigen doses may occur due to an expansion of 
the small number of thymus cells which had peripheralized prior to the 
time of thymectomy.
In vivo cellular cooperation. The f irs t direct evidence for the 
participation of thymus-derived lymphocytes and bone marrow-derived 
lymphocytes in the immune response came from the work of Cl aman and co­
workers (Cl aman, Chaperon, and Trip lett, 1966a, 1966b; Cl aman and 
Chaperon, 1969). These investigators reported that reconstitution of 
lethally irradiated recipients with thymus cells and bone marrow cells 
followed by injection of an immunizing dose of sRBC resulted in immune 
responses which were higher than the additive response of either cell 
type was given alone. They called this phenomenon bone marrow cell-thymus 
cell synergism.
Cl aman. Chaperon, and Seiner (1968) observed that the thymus- 
dependent cell must be living. Transfer of sonicated or irradiated 
thymus cells along with normal bone marrow cells was ineffective in 
synergy experiments.
The experiments of Miller and Mitchell (1967), Mitchell and 
Miller (1968a, 1968b), and Miller and Mitchell (1969) confirmed the ob­
servation of Cl aman and colleagues that two types of lymphoid cells were 
required for the anti-sheep erythrocyte response. They reported that a 
significant plaque forming cell response occurred in the spleens of 
lethally irradiated mice which had been given bone marrow cells, sRBC 
and spleen cells from donors which were irradiated and injected with 
thymus cells and sheep erythrocytes one week previously. No responses 
occurred in recipients i f  the primary recipient was injected with thymus
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cells only. Responses were also negative in secondary recipients when 
bone marrow cells were not inoculated.
Miller and Mitchell (1968) reported that the anti-sRBC response 
of neonatally thymectomized animals was restored to normal levels by in ­
jections of normal syngeneic or allogeneic thymus or thoracic duct lympho­
cytes. There was no significant increase in the anti-sRBC response of 
thymectomi zed mice i f  they were given bone marrow cells, irradiated thy­
mus cells, irradiated thoracic duct cells, thymus extracts, or yeast 
cells. When the recipient was reconstituted with semi-allogeneic cells, 
anti-H-2 antiserum treatment of the recipient spleen cells just prior to 
determination of the RFC response allowed identification of the antibody 
forming cells as being of host origin. Cross, Leucars, and Miller (1964)
reported that normal spleen cells, but not spleen cells of thymectomized
donors, would restore the immune response in mice which had been
thymectomized, irradiated and bone marrow protected.
Nossal, Cunningham, Mitchell and Miller (1968),using the fu lly  
syngeneic CBA and CBA/T6T6 donor-recipient combination, observed that 
neonatally thymectomi zed mice were rendered responsive to sRBC immuniza­
tion by transferred thymocytes. The antibody forming cell was of the 
recipient type as judged by chromosome analysis. Likewise, in lethally 
irradiated animals reconstituted with mixtures of chromosomally marked 
bone marrow or thymus cells, the antibody forming cells were determined 
to originate from the bone marrow inoculum.
Miller and coworkers concluded from their experiments that in 
the mouse the precursor of the antibody forming cell (AFC) was of bone 
marrow origin, but that a specific thymus cell-antigen interaction must
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occur which in some manner potentiates the differentiation of the AFC 
precursor. This theory was substantiated by the results of Shearer and 
Cudkowicz (1969) who found thymic antigen reactive cells (ARC) which were 
capable of in itia ting the anti-sRBC response in this species. They noted, 
in addition, that the ARC must interact specifically with antigen.
Normal bone marrow cells adoptively transferred immunity to 
sRBC to irradiated rabbits in the experiments of Abdou and Richter (1969a) 
and Richter, Rose and Abdou (1970). The bone marrow cells of the rabbit 
were identified as the ARC when Richter and Abdou (1969) discovered that 
in the x-irradiated rabbit, host cells were the precursor of the AFC. 
Abdou, Rose and Richter (1969) reported that the bone marrow ARC was 
radiosensitive. These workers (Abdou and Richter 1969b, 1970b) observed 
that i f  bone marrow cells were harvested 24-48 hrs following immunization 
they were unable to transfer iimunity to the antigen used for priming. 
These same cells were fu lly  capable of adoptively transferring immune 
responses to other antigens. They postulated that ARC migrated out of 
the bone marrow after antigenic stimulation and transferred information 
to the AFC in some other organ. Abdou and Richter (1970c) identified 
cells in the rabbit sacculus rotundus as the AFC in that species.
The phenomenon of thymus cell-bone marrow cell collaboration 
in avian species has not been extensively investigated, however a few 
recent reports have indicated that such cellular collaboration may occur. 
Gilmour, Thies and Thorbecke (1970) transferred cells (bursal, thymus 
or spleen) from chickens isogeneic for the strong B histocompatibility 
locus to irradiated chicks one day after hatching. They found that only 
spleen cells were effective in transferring the sRBC response when
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antigen was given immediately after transfer. In tests of synergism by 
mixtures of cell populations, they observed a modest augmentation of the 
sRBC response when animals were reconstituted with bursal cells and spleen 
cells as compared to spleen cells alone. McArthur, Gilmour, Hochwald, 
and Thorbecke (1971) pretreated spleen cells with anti-thymus serum be­
fore transfer and were no longer able to adoptively transfer the primary 
sRBC response to x-irradiated, recipient chickens. Synergistic effects 
were noted by mixtures of chicken bone marrow and thymus cells i f  cell 
doses were lower than the threshold dose for consistent RFC responses 
when the cells were administered singly (McArthur, Gilmour and Thorbecke,
1972). The evidence for thymus-bursal cell synergy was only suggestive. 
These investigators proposed that the reason for this observation might 
be the variable background responses of bursal cells along with the lack 
of a third cell type required in this system.
Rouse and Warner (1972) reported reduced antibody titers to 
horse erythrocytes and DNP-BSA in chickens deprived of thymus-dependent 
cells by a treatment which combined neonatal thymectomy with anti-chicken 
thymus serum. Thymus-deprived chickens responded to injections of 
Brucella with agglutinin titers which were not significantly different 
from controls.
In vitro cellular cooperation. The in vitro antibody production 
technique of Mishell and Dutton (1967) has been utilized extensively in 
studies of thymus cell-bone marrow cell collaboration during the immune 
response. Such investigations have further substantiated the phenomenon 
of thymus-bone marrow cooperation originally observed in studies of employ­
ing reconstituted, irradiated animals.
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Spleen cells from thymus-deprived mice do not respond in vitro 
to sRBC (Hosier, Fitch, Rowley and Davies, 1970; Munro and Hunter, 1970; 
Rosenoer, Biano and Brown, 1970; Hirst and Dutton, 1970; Aden, Reed, and 
Jutila, 1972). Hosier et a l. (1970), Rosenoer et a l. (1970) and Hirst 
and Dutton (1970) determined that the cellular defect in thymectomized 
mice was in the non-adherent cell population. Others (Doria, Martinoz, 
Agarossi and Dipietro, 1970; Munro and Hunter, 1970; Aden, Reed and 
Jutila, 1972) reported that addition of thymocytes to spleen cell cul­
tures of thymus-deprived mice restored responsiveness toward sheep 
erythrocytes.
Hartmann (1970, 1971) prepared thymus-dependent cells from 
spleens of irradiated mice one week after injection of thymus cells and 
sheep erythrocytes (educated T cells). Bone marrow-derived cells were 
obtained from spleens of thymectomized, irradiated, bone marrow-grafted 
animals. Both cell types were necessary for an in vitro response to 
sRBC. He found that the T-cell must be "educated" with the specific 
antigen used for in vitro stimulation. When T-cells and B-cells were 
cultured with two different RBC antigens, one of which was used to edu­
cate the T-cell, a RFC response occurred against both erythrocytes.
This observation was confirmed by Hunter, Munro and McConnell (1972) and 
by Kettman and Dutton (1971). The number of RFC detected after 3 to 4 
days of culture was directly proportional to the number of T-cells added 
to the culture. Thymus-dependent lymphocytes were found to promote 
clone expansion,since higher concentrations of T-cells led to shorter 
doubling times for RFC.
Vann and Kettman (1972) confimed the observation of Hartmann
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(1970, 1971) and further reported that bone marrow-derived cells could 
be inactivated by exposure to 2000 R gamma-irradiation while educated 
T-cells were not. This result was in agreement with those of Katz et a l.
(1970) and Kettman and Dutton (1971) who reported radioresistance of 
carrier-primed cells. Using TPN-sRBC, Vann and Kettman found that re­
sponses occurred against the DNP determinant to which neither the T-cell 
nor the B-cell populations had been previously exposed. In these experi­
ments sheep erythrocyte "educated",thymus-dependent cells were analogous 
to carrier-primed spleen cell populations.
Consequences of anti-theta anti serum treatment. Anti serum pre­
pared against the theta antigen found on thymocytes of mice has been 
used to study the various functions of thymus-derived lymphocytes. 
Generally, such experiments involved treating cells in vitro with anti- 
theta serum and complement followed by assaying the iimune competence 
of the treated cell suspensions in vitro or in adoptive hosts. Several 
investigators have reported that immune plaque forming cells or their 
precursors were not directly affected by anti-theta serum (Greaves and 
Mol 1er, 1970; Takahashi, Carswell and Thorbecke, 1970; Cerottini, Nordin 
and Brunner, 1970; Raff, 1971; Chan, Mishell and Mitchell, 1970).
Schimpl and Meeker (1970) observed a reduction of the in vitro response 
of spleen cells to sRBC when the cells were treated with anti-theta and 
complement prior to culture. This response was partially restored by 
the addition of thymus cells to the anti-theta treated spleen cell cul­
tures. Chan et a l. (1970) reported similar observations and determined 
that the response of spleen cells treated with anti-theta could be re­
stored by the addition of "educated" thymus-derived cells.
37
The studies of Takhashi, Carswell and Thorbecke (1970, 1971) 
revealed that anti-theta antiserum treatment abolished the ab ility  of 
mouse spleen cells to transfer both primary and secondary responses 
against sRBC to irradiated recipients. They obtained partial reconsti­
tution of the primary response by addition of normal thymocytes to anti- 
theta treated spleen cells. Normal thymus cells did not reconstitute 
the secondary response, however. Primary and secondary responses against 
Brucella abortus were not reduced by treating spleen cells with anti- 
theta serum.
Raff (1970) reported that theta-positive cells were required 
for secondary responses to hapten-carrier protein conjugates. Treatment 
of primed helper cells with anti-theta markedly depressed the anti-NIP 
response when these cells were transferred to irradiated animals chal­
lenged with BSA-NIP. Treatment of NIP-chicken gamma globulin primed 
cells had no effect on the secondary adoptive anti-NIP response. These 
results demonstrated that the role of theta-positive cells in the immune 
response was one of specific antigen handling rather than secretion of 
antibody.
The Mechanism of Cellular Collaboration
Several theories have been proposed to explain the mechanism 
whereby thymus-dependent cells assist bone marrow-derived cells during 
in itia tion  of antibody synthesis. Talmage, Radovich and Hemmingsen 
(1969) suggested two different three cell models for antibody formation. 
In both models the adherent cell was capable of binding antigen. This 
ce ll's  function was to bring the two non-adherent cells together. One 
model proposed that the thymus-dependent cell was antigen specific and
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made a messenger RNA which was transferred to the bone marrow-derived 
ce ll. The B-cell then provided the ribosomes and synthesized antibody. 
Abdou and Richter (1970a) also speculated that antigen specific ARC 
transferred specific information to uncommitted antibody forming cell 
precursors. The second model of Talmage et a l. stated that the T-cell 
was a delayed hypersensitivity cell which upon contact with specific 
antigen greatly enhanced the interaction of macrophage and bone marrow- 
derived cell.
There is no experimental evidence to support the contention that 
ARC or T-cells transfer specific information to antibody forming cells 
via RNA. I t  is known that both the subclass of immunoglobulin and allo­
type of antibody formed are characteristic of the B-cell and that thymus 
cells are not specialized for molecular class of antibody (Klein and 
Herzenberg, 1967; Shearer, Cudkowicz and Priore, 1969a, 1969b, 1969c; 
Shearer and Cudkowicz, 1969; Cudkowicz, Shearer and Priore, 1969). 
Although this does not rule out the possibility that the T-cell may 
transfer a limited amount of information to the B-cell, i t  makes i t  
highly unlikely that the T-cell alone determines the structure of the 
immunoglobulin produced. The T-cell could, however, transfer the infor­
mation for the variable region of H and/or L chains where antibody 
specificity is determined.
I t  was proposed by Mitchison (1969b, 1969c) that thymus-depend­
ent lymphocytes produced a nonsecretable immunoglobulin which he named 
IgX. He suggested that antigen was bound to the IgX receptors on the 
thymocyte surface. This interaction would allow the antigen to be pre­
sented to B-cells in the proper concentration to trigger antibody
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formation. Mitchison's mode! required that determinants recognized by 
B-cells and T-cells must be associated with the same molecular structure.
Miller et a l. (1971) determined that triggering of unprimed 
B-cells could not be accomplished by antigen coated tolerant T-lympho- 
cytes. Treatment of primed or unprimed T-cells with mitomycin C im­
paired their "helper" activity, suggesting that T-cells must be activated 
by antigen to differentiate and during this process they may produce 
some factor essential for triggering B-lymphocytes.
Surface membrane interactions between specialized receptors on 
B-cells and T-cells,other than antigen-specific receptors,have been 
speculated by Dutton et a l. (1971) to be another alternative to explain 
thymus cell-bone marrow cell collaboration. Such interactions would be 
facilitated by antigen bridges between immunoglobulin receptors on B 
and T lymphocytes.
Bretscher and Cohn (1968, 1970) proposed chat thymus-dependent 
lymphocytes secrete an as yet unidentified antibody called "carrier" 
antibody. They suggested that induction of humoral antibody formation 
involved the recognition of two determinants of an antigen; one by re­
ceptor antibody molecules on the surface of the AFC and a second by 
carrier antibody. I f  antigen alone was recognized by the AFC receptor, 
paralysis would ensue. Recent reports in the literature have lent 
support to this hypothesis (Kennedy, Treadwell, and Lennox, 1970;
Feldman and Basten 1972a, 1972b).
Kennedy, Treadwell and Lennox (1970) observed synergism in 
anti-erythrocyte responses between bone marrow and peritoneal cavity 
cells when both cell types were used to reconstitute irradiated
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recipients. They noted that heat-killed peritoneal cells or extracts of 
these cells were also effective. The phenomenon was determined to be 
antigen specific. Because peritoneal cavity cells or their extracts 
were not immunogenic when tested in primed animals, they believed that 
antigen was not present in their preparations and that the effect noted
was due to some sort of immunoglobulin.
In 1971, Feldmann and Basten reported that thymocytes were not 
required for in vitro immune responses to polymerized flagellin but that 
T-cells were necessary to e lic it  an immune response to monomeric 
flagellin or erythrocytes coated with monomeric flagellin . The fact 
that comparable levels of antibody forming cells to these three forms of 
the same antigen occurred in normal or x-irradiated, bone marrow grafted 
animals, suggested that the mechanism of immune induction was the same 
for each antigen form. Further studies using a hapten determinant 
coupled to a thymus-independent carrier (polymerized flagellin , POL) or 
a thymus-dependent carrier (donkey red blood cells, dRBC) showed that 
immune responses in adult thymectomized, bone marrow repopulated mice 
only occurred against DNP-POL. I t  was apparent, therefore, that thymus- 
dependency was related to the mode of presentation of antigenic deter­
minants rather than to their specificity. These observations seemed to
f i t  the hypothesis presented by Mitchison (1968, 1969) that T-cells
stimulate B-cells through an antigen "focusing" mechanism. However, 
further investigations by Feldmann and Basten (1972a, 1972b) revealed 
that when carrier and hapten primed T-cells and B-cells were placed in 
separate compartments on either side of a cell impermeable membrane 
along with antigen, excellent cooperative responses occurred. They
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noted that the restorative effect of the thymus-derived cell product 
was antigen specific. Feldmann and Basten (1972b) reported that T-cell 
helper activity required no further cell division after in itia l priming, 
but that i t  was abolished by inhibitors of RNA and protein synthesis. 
Feldmann (1972b) has determined that thymus-bone marrow interactions do 
not occur in the absence of macrophages. Feldmann and Basten suggested 
that thymus-dependent cells elaborate an IgX which is complexed with 
antigen. They believe that IgX-antigen complexes may bind to the sur­
face of macrophages where a lattice of repeating antigenic determinants 
is formed. Bone marrow-derived RFC precursors would then be stimulated 
when they encountered antigen having repeating determinants. Schmidtke 
and Unanue (1971b) found that B-cells preferentially bind to macro­
phages, and the ultrastructural studies of Miller and Avrameas (1971) 
pointed to a close association between macrophages and cells synthesizing 
antibody.
Another model for thymus cell-bone marrow cell cooperation 
which is supported by some experimental evidence postulates the exist­
ence of a chemical mediator elaborated from thymus dependent cells 
(Dutton e ta l ., 1971). This scheme proposes that a B-cell is stimulated 
after i t  receives two signals. The f ir s t  signal occurs upon the inter­
action of antigen with receptor molecules on the surface of the AFC 
precursor. The second signal is a diffusable chemical mediator which 
results from the interaction of antigen with thymocyte receptors. The 
chemical mediator is its e lf nonspecific, its  only limitation being the 
effective distance of its  diffusion gradient. The experiments of 
Hartmann (1970) and Kettman and Dutton (1971) showed that when
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thymus-dependent cells "educated" with antigen x which were cultured 
along with bone marrow-derived cells they responded to antigen y provided 
that both antigen x and antigen y were present.
A second type of experiment has been reported in which chemical 
mediators may be liberated in larger quantity. Such a case arises when 
allogeneic, non-adherent cells are used to restore immune responses of 
bone marrow-derived cells. Hirst and Dutton (1970) found that a llo­
geneic spleen cells were more effective than syngeneic cells in restor­
ing the in vitro immune response of spleen cells taken from neonatally 
thymectomized mice. The effect of allogeneic cells was even greater 
i f  these cells were x-irradiated prior to addition to the spleen cell 
cultures. Dutton and coworkers (1971) suggested that in this system a 
chemical mediator was produced by T-cells in response to the histocom­
pa tib ility  antigens present on the B-cells. They proposed that irradia­
tion inhibited the cytotoxic activity of T-cells but did not inh ib it 
the production of this nonspecific chemical mediator. The work of 
Hirst and Dutton was confirmed by the studies of Kennedy and 
Ekpaha-Mensah (1971). Analogous results have arisen from the observa­
tion of Katz, Paul, Goidl and Benacerraf (1971) that a graft-versus-host 
(GVH) reaction would stimulate an anti-DNP response in ovalbumin-DNP 
primed mice in the absence of further antigenic challenge. McCullagh 
(1970b) observed that transfer of allogeneic lymphocytes abrogated 
tolerance of rats unresponsive to sRBC. Because the PFC detected were 
mainly of host origin, i t  appeared that the GVH reaction produced by 
the allogeneic cells had liberated chemical mediators capable of stimu­
lating nonresponsive host lymphocytes.
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Cellular Sites of Immunologic Unresponsiveness
Delineation of the cells required for induction of immunity 
provided a foundation for further investigations of the cellular sites 
of immunological tolerance. These studies have located the cellular 
"lesions" which may occur in the unresponsive animals. Hopefully, the 
subcellular mechanism of immune tolerance w ill soon be elucidated.
The Macrophage
Early attempts at tolerance induction were only successful in 
neonatal animals (Smith, 1961). This fact, along with the observation 
that neonates had an immature reticuloendothelial system (Karthigasu 
et a l., 1965; Reade and Jenkin, 1965) led to speculation that inab ility  
of macrophages to process antigen may be the critica l event in tolerance 
induction.
Mitchell and Nossal (1966) reported that cells of newborn ani- 
125mais did not phagocytose I-labeled salmonella flagellin and that this 
antigen was distributed diffusely throughout the lymphoid tissue of the 
neonate, including the thymus. This finding was in contrast to results 
in adult animals where antigen was phagocytized efficiently and was con­
centrated in lymphoid fo llic les . Others (Argyris, 1968; Martin, 1966) 
reported that poor immune responses in neonates and ease of tolerance 
induction could be attributed to lack of phagocytic function.
Ada, Nossal and Pye (1965) studied the localization of S^. 
adelaide flagellin in lymphoid organs of normal and tolerant animals. 
They found that tolerant animals handled antigen in a manner comparable 
to normal controls. Similar observations were reported by Humphrey and 
Frank (1967).
44
Peritoneal cells from normal rabbits or rabbits tolerant to 
BGG were reported by Harris (1967) to be equally able to engulf antigen 
and stimulate DNA synthesis of spleen cell suspensions of immune rabbits. 
Mitchison (1969a) determined that peritoneal exudate cells of BSA 
paralysed donors were as effective as PEC of normal donors in processing 
BSA antigen for subsequent immune responses upon transfer to normal 
recipients.
Although the macrophage was shown to be fu lly  functional in 
tolerant animals, i t  has been determined that procedures which cause 
decreased phagocytosis favor tolerance induction. The physical state of 
antigen has been found to influence the ab ility  of that material to in ­
duce immunity or tolerance. Soluble antigens are generally more tolero­
genic and less well phagocytized than are particulate antigens. 
Aggregate-free preparations of protein solutions prepared by high speed 
ultracentrifugation (Dresser, 1962; Gamble, 1966; Weigle and Golub,
1957; Biro and Garcia; 1965) or by "biological filtra tio n " (Frei et a l., 
1965; Golub and Weigle, 1969) are highly tolerogenic. Conversely, these 
same antigens when in an aggregated state favoring their uptake by 
phagocytes are highly immunogenic (Biro and Garcia, 1965). Neill (1970) 
reported that treatment of BALB/c mice with RES depressants enhanced 
induction of tolerance or a hyporesponsive state to human gamma globulin. 
This observation supported the contention that i f  antigen is not pro­
cessed appropriately by macrophages tolerance may ensue.
The Lymphocyte
Early reports of a specific inability of lymphocytes derived 
from immunologically tolerant donors to transfer adoptive immune
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responses to x-irradiated recipients pointed out the lymphocyte as the 
cellular site of immunologic unresponsiveness (Dietrich and Weigle, 1964; 
Denman, Vischer and Stastney, 1967). Since the discovery that T-cells 
and B-cells may participate in humoral immune responses, much effort 
has gone into studies designed to test which of these cells becomes 
tolerant in the unresponsive animal.
Tolerance in thymus cells has been observed by several investi­
gators. Isakovic et a l. (1965) were able to restore immune responses of 
thymectomized, irradiated, bone marrow protected mice with normal thymus 
grafts. Thymus grafts from tolerant animals did not enable the recipi­
ent to respond to the tolerated antigen. Taylor (1968, 1969) found that 
thymus cells obtained from donors treated 24 hrs previously with 10 mg 
BSA would not cooperate with normal bone marrow cells in the anti-BSA 
response. Bone marrow cells taken from the same tolerogenized donors 
were fu lly  competent to e lic it  an antibody response to BSA when in 
combination with normal thymus cells. Tolerance in thymocytes taken 
from mice treated with sRBC plus cyclophosphamide was reported by Many 
and Schwartz (1970), while no tolerance was observed in the bone marrow 
cell population of these animals. Miller and Mitchell (1970) obtained 
cyclophosphamide-induced tolerance in peripheralized, thoracic duct, 
thymus-dependent lymphocytes, but they could not detect unresponsive­
ness in lymphocytes resident within the thymus. They reported further 
that bone marrow cells of their sRBC tolerant animals were fu lly  capable 
of cooperating with normal thymus-derived cells in the anti-sheep 
erythrocyte response. Inability to render bone marrow cells unrespon­
sive by treatments which employ cyclophosphamide may be explained by the
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fact that antigen in it ia lly  stimulates T-cells (Davies et a l., 1966). 
Cyclophosphamide affects cells which have been induced to proliferate. 
Because the T-cell helper function is required for B-cell stimulation, 
in it ia l suicide of T-cells leaves B-cells unstimulated and unaffected by 
the drug.
Playfair (1969) induced tolerance in (NZB x BALB/c)mice 
using an erythrocyte-cyclophosphamide tolerance inducing regimen. He 
could not detect suppression of thymocytes in these experiments. In a 
later communication, Playfair (1971a) reported that tolerance could be 
induced in thymus cells of BALB/c or young (NZB x BALB/c)hybrids but 
not in older F-j hybrids, NZB adults, or young NZB mice.
Many of the inconsistencies observed in tolerance induction of 
bone marrow cells have been explained by the work of Chiller and 
colleagues (Chiller and Weigle, 1970; Chiller, Habicht, and Weigle,
1970, 1971; Weigle, Chiller and Habicht, 1972). In in it ia l experiments. 
Chiller and coworkers (1970) assayed bor.e marrow and thymus cells taken 
from mice injected 17 days previously with deaggregated human gamma 
globulin (soluble HGG, sHGG) for their ab ility  to cooperate with their 
normal counterparts in the anti-HGG response. They found that thymus 
cells and bone marrow cells of sHGG-treated donors were unable to syner- 
gize with normal cells in the anti-HGG response. Animals treated with 
these cell combinations did respond to injections of turkey gamma 
globulin. These investigators (Chiller, et a l., 1971) studied the 
kinetics of induction and spontaneous loss of tolerance in both bone 
marrow and thymic lymphocytes. At various times after tolerance
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induction, tolerant bone marrow cells or tolerant thymus cells were 
transferred along with appropriate normal cells to lethally irradiated, 
syngeneic recipients. The anti-HGG response obtained in these animals 
after two challenges of heat aggregated HGG was compared with responses 
obtained in animals reconstituted with normal thymus and normal bone 
marrow cells. Thymus cells became 90 per cent unresponsive within 24 
hrs of tolerogen administration and 100 per cent tolerant within 120 hrs. 
Thymocytes remained tolerant for a prolonged period before they re­
turned to a responsive state by the 135th to 150th day. In contrast, 
tolerance in the bone marrow cell population did not begin to appear 
until 8 days after injection of sHGG, and i t  was not complete until the 
21st day. Tolerance of the bone marrow cell population was not long 
lasting and by day 49 these cells had returned to normal responsiveness. 
Not only did thymus cells and bone marrow cells d iffe r in regard to 
kinetics of tolerance induction, but they were distinctly different in 
their sensitivity to various doses of sHGG. Tolerance was induced in 
thymus cells with as l i t t le  as 0.01 mg deaggregated HGG,whereas bone 
marrow cells did not become tolerant unless at least lOOX more tolerogen 
was injected. Failures by other investigators to detect unresponsive­
ness in bone marrow cells could be explained by the fact that their 
assays of the immune potential of bone marrow cells from tolerant mice 
were carried out at a time when these cells would not be expected to be 
tolerant. Alternatively, these investigators may have used an insuffi­
cient amount of antigen for tolerance induction in the bone marrow cell 
population.
The discovery that thymus-dependent lymphocytes may be tolerant
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in the unresponsive animal, while bone marrow-derived lymphocytes are 
not, helped explain previous observations that immune tolerance to 
albumins could be broken by injection of cross reacting albumins (Weigle, 
1951; Weigle, 1965c; Benjamin and Weigle, 1970a, 1970b) or with albumins 
which had been chemically modified (Weigle, 1962; Paul, Thorbecke, 
Siskind, and Benacerraf, 1969). Paul and coworkers (1969) used DNP-BSA 
to terminate the unresponsive state of rabbits to BSA. Termination of 
tolerance could only be accomplished i f  the animals had been rendered 
tolerant by small but not large BSA doses. Normal levels of binding 
and precipitating antibodies to BSA were found by Benjamin and Weigle 
(1970a) in BSA-tolerant rabbits treated with cross reacting albumins.
In addition, the antibody produced in the tolerant rabbits was quali­
tatively the same as that produced in normal animals. Benjamin and 
Weigle (1970b) observed that injections of BSA into BSA-tolerant rabbits 
which had been treated two months previously with cross reacting al­
bumins resulted in the production of antibodies which were only directed 
against determinants shared by BSA and the albumin used for tolerance 
termination. I f  bone marrow cells were responsive in these animals, one 
would expect that thymus cells could react with determinants on the 
cross reacting albumin which were unrelated to those of BSA,while bone 
marrow cells could recognize determinants shared by BSA and the termin­
ating albumin.
Chiller and Weigle (1972) determined the cellular requirement 
for rescue of immunocompetency of spleen cells of mice treated three 
days previously with deaggregated HGG. At this time period, i t  was ex­
pected that the T-cells in the spleen would be unresponsive,while B-cells
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would be competent to respond to immunogenic HGG. Surprisingly, supple­
mentation of tolerant spleen cells with normal thymus cells or normal 
bone marrow cells did not reverse the unresponsive state. When both 
normal bone marrow cells and normal thymus cells were added to tolerant 
spleen cells, immune responses were detected in reconstituted, x-irradi- 
ated recipients. These experiments suggested that peripheralized B-cells 
may become tolerant in a shorter period of time than do B-cells resident 
in the bone marrow. Such results agree with reported tolerance induc­
tion in vitro with thymus-independent antigens where unresponsiveness, 
presumably of B-lymphocytes, has been observed after brief exposure to 
antigen (Britton, 1969; Feldmann, 1971, 1972b; Diener and Armstrong,
1969; Feldmann and Diener, 1970).
The fate of cellular receptors for antigen in unresponsive mice
was studied by Louis, Chiller and Weigle (1972). They determined the
125number of cells which could bind I-HGG as time passed following in­
jection of sHGG. There was a marked decrease in antigen binding cells 
(ABC) in the spleens of tolerogenized mice as early as 12 hrs after sHGG 
administration. Optimal reduction occurred at five days and remained 
at this level for at least 20 days. Antigen binding cells increased in 
mice immunized with aggregated-HGG beginning as early as 12 hrs after 
injection and reaching a peak at 3 days. Normal, immune and tolerant 
mice had equal numbers of ABC in the bone marrow until day 20 when there 
was a marked reduction of ABC in the bone marrow of tolerogen-treated 
mice. These results disagreed with the work of others (Humphrey and 
Keller, 1970; Ada et a l., 1970; Sjoberg and Mol1er, 1970; Howard et a l., 
1969) who observed numbers of ABC in tolerant animals equal to or
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greater than that observed in normal animals. Near and Sulitzeneau 
(1957) and Katz, Davie, Paul and Benacerraf (1971) reported reduced 
numbers of ABC in tolerant animals. Differences in reported numbers of 
ABC in tolerant animals might be explained by the possibility that both 
bone marrow cells and thymus cells were not tolerant in animals where 
normal or increased numbers of ABC were observed. Additionally, investi­
gators who have observed increased ABC in unresponsive animals have used 
antigens which are not efficient to ierogens (Weigle, Chiller, and 
Habicht, 1972).
I t  was proposed by Gershon and Kondo (1970) that tolerance in­
duction in bone marrow cells may require the cooperation of thymus- 
dependent cells. They were unable to induce tolerance in thymus- 
dependent, bone marrow-derived cells unless thymocytes were present 
during the induction period. These workers (Gershon and Kondo, 1971) 
reported that tolerant spleen cells transferred along with normal thymus 
and bone marrow cells to irradiated recipients prevented the cooperative 
effect of the normal cells in an anti-sRBC response. Spleen cells from 
normal mice or from mice tolerogenized in the absence of thymus-derived 
cells did not effect cellular cooperation in the immune response to 
sheep erythrocytes. The ab ility  of tolerant spleen cells to abolish 
immune responses was specific for the antigen to which the spleen cells 
were unresponsive. Gershon and Kondo suggested that tolerant thymus- 
dependent cells produce an immunosuppressive substance (IgY). Alterna­
tively, unresponsive T-cells may influence bone marrow-derived cells to 
secrete this material. Chiller and Weigle (1972) could find no evi­
dence that HGG-tolerant cells would inhib it responsiveness of normal
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cells. Howard et a l. (1972) determined that induction of tolerance to 
pneumococcal polysaccharide could be accomplished in bone marrow cells 
in the absence of thymus-dependent cells.
Statement of Problem 
Golub and Weigle (1969) observed that various strains of inbred 
mice differ in their ab ility  to be rendered immunologically tolerant 
with ultracentrifuged human gamma globulin (sHGG). The BALB/c strain 
which was highly refractory to the induction of the unresponsive state, 
and the C57BL/6 strain was highly susceptible to induction of tolerance 
with sHGG. The F.j hybrid of a cross-mating between BALB/c and C57BL/6 
mice behaved as its  C57BL/6 parent in regard to its  ease of tolerance 
induction. The present investigation was undertaken to evaluate the 
cellular basis (thymus cell and/or bone marrow cell) for the observed 
variation among these three strains of mice to induction of the unrespon­
sive state.
CHAPTER II  
MATERIALS AND METHODS
Experimental Animals
Male BALB/c, C57BL/6 and CBF^  (BALB/c x C57BL/6) mice were pur­
chased from Simenson Laboratories, Gilroy, California. The mice were 
seven weeks of age at the time of arrival and were used experimentally 
when they were 8 to 12 weeks old. In one experiment, female CBF.j mice 
were employed. The animals were fed Tekland Mouse/Rat Diet and tap 
water ad libitum. Animals used as irradiated recipients of syngeneic 
cells were maintained for one to two weeks prior to irradiation on water 
which contained a 1:4000 dilution of chlorox. After irradiation and 
cell transfer animals were housed no more than three to a cage and were 
continued on chlorinated water for the duration of the experiment.
Goats used for preparation of amplifying antiserum were ob­
tained locally. They were fed a diet of Purina meal (#2535M) and water 
ad libitum.
Antigens
Human gamma globulin (HGG, Cohn Fraction II) in lyophilized 
form was generously supplied by the American Red Cross. Various prep­
arations of this material were used for tolerance induction, antigenic 
challenge and assay of the immune response.
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Soluble Human Gamma Globulin 
An aggregate-free preparation of human gamma globulin,designated 
soluble human gamma globulin (sHGG)jWas used for tolerance induction. 
Lyophilized HGG was dissolved in physiological saline solution (0.85 per 
cent NaCl) at room temperature. The solution was centrifuged for 150 
min using a swinging bucket rotor (SW41) at 100,000 X G, 4 C, in a 
Beckman Model L2-65B preparative ultracentrifuge. After centrifugation 
the upper one third of the material in each cup was carefully removed, 
taking care to avoid agitation of the protein solution. The protein 
concentration of the solution was determined spectrophotometrical1y by 
the method of Kalckar (1947) using a Perkin-Elmer double beam spectro­
photometer (Coleman 124). Animals were injected with a volume of the 
sHGG solution sufficient to contain the amount of tolerogen desired.
The volume injected was approximately 0.5 ml. All animals were injected 
within 20 to 30 min following centrifugation of the protein solution.
Aggregated Human Gamma Globulin 
For immunogenic challenge, a heat aggregated form of HGG 
(agg-HGG) was prepared according to the method of Biro and Garcia (1965). 
Forty m illilite rs  of a saline (0.85 per cent NaCl) solution of HGG con­
taining 25 mg protein per ml was dialyzed in the cold (4 C) for 24 hrs 
against two changes of 0.01 M phosphate buffer (pH 8.0) made up in dis­
t ille d , deionized water. The buffer contained 0.49 gm KHgPO^ and 11.23 
gm NaHPO^ in 6 1 d istilled  water. After dialysis the HGG solution was 
centrifuged in an International clinical centrifuge to remove any pre­
cipitate. The supernatant fluid was removed and was heated at 63 C for 
20 min with occasional stirring. Timing of heat treatment was begun
54
when the solution in the flask reached 63 C. After heating, the pro­
tein solution was cooled in an ice bath for 2 hrs. The aggregated ma­
teria l was collected by centrifugation at 1000 X G for 15 min in an 
International PR-1 refrigerated centrifuge and was washed three times in 
phosphate buffer. After the final wash the aggHGG was resuspended in 
20 ml saline. One m il l i l i te r  of aggHGG was digested in 4.0 ml 0.01 N 
NaOH for th irty  min. The protein concentration of the digest was deter­
mined spectrophotometrical ly (Kalckar, 1947). The original suspension 
of aggHGG was diluted with saline to contain 2.0 mg protein per ml and 
was frozen (-20 C) in 5 ml aliquots until used. Aggregated antigen was 
used within 45 days of its  preparation.
Preparation of Amplifying Anti serum 
Goat anti-mouse globulin used to develop indirect plaque form­
ing cells in the localized hemolysis-in-gel assay was prepared as 
follows. Goats were given three injections (subcutaneously in four 
sites) of 10 mg mouse gamma globulin (Cohn Fraction I I ,  Pentex, Inc., 
Kankakee, Illino is , lo t #9) suspended in 5 ml incomplete Freund's 
adjuvant. The injections were spaced three weeks apart. Three weeks 
after the final injection the goats were bled and their serum tested 
against a control for its  ab ility  to detect antibody forming cells in 
the spleens of mice undergoing a secondary response to aggHGG. Amplify­
ing serum kindly supplied by Dr. Jacques Chiller (Scripps Clinic and 
Research Foundation, La Jolla, California) was used as the reference 
control. This serum was also used experimentally in some cases.
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Immune Response Assay
The immune response of experimental animals was evaluated by 
the localized hemolysis-in-gel assay of Jerne, Nordin and Henry (1963) 
as modified by Golub et a l. (1968). Goat erythrocytes (gRBC) preserved 
in A1seven's solution (Animal Blood Center, Syracuse, N. Y.) were aged 
upon receipt for four weeks. The red blood cells were washed three 
times in conjugation buffer (CB) containing 4.35 gm NaCl, 2.4 gm KHgPO^ 
and 10.50 gm NagHPO^ per 1 d is tilled , deionized water. The pH of the 
buffer was adjusted to 7.2 using the appropriate 0.15 M salt.
A soluble carbodiimide (1-ethyl-3-(3-di methyl ami nopropyl) 
carbodiimide HCl, ECOI, Ott Chemical Co., Muskegon, Michigan) was used 
to couple human gamma globulin to gRBC. Four tenths ml of a 50 per cent
erythrocyte suspension in CB were added to 3 ml of a 20 mg per ml solu­
tion of HGG in CB. The HGG solution had been previously absorbed with 
fresh gRBC. Five tenths ml of an ECOI solution in CB containing 100 mg 
per ml was then added to the erythrocyte-protein mixture. The ECDI 
solution was made up immediately before addition to the reaction mixture.
The suspension was incubated at 4 C for 1 hr and was centrifuged at
1,500 rpm for 5 min. The red cell pellet was washed two times in CB and 
once in Hank's balanced salts solution (HBSS, Microbiological Associates, 
Bethesda, Maryland). The erythrocytes were suspended in HBSS to a final 
concentration of 7 per cent. Control cells were prepared in a manner 
similar to the HGG-conjugated cells except 3 ml of CB were substituted 
for the HGG solution. In some cases coupled erythrocytes were used as 
many as three days after conjugation» in these instances the red blood 
cells were washed IX in HBSS on the day of use and were resuspended in
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HBSS.
Animals were sacrificed by cervical dislocation and their spleens 
removed for preparation of spleen cell suspensions. Single cells were 
obtained by pressing spleens with a pair of forceps through a 60 mesh wire 
screen into cold HBSS. The cells were filtered through #80 mesh silk 
screen into a tube (15 x 100 m). The spleen cell suspensions were cen­
trifuged for 10 min at 1,000 X G in an International refrigerated centri­
fuge (PR-1) at 4 C. The pellet was resuspended in 5 ml 0.83 per cent 
NH^ Cl and allowed to stand at room temperature for 5 min to lyse the red 
cells present in the preparation. The cells were again spun down and were 
washed three times in cold HBSS. After the final wash the cells were 
resuspended in 2.0 ml HBSS, and the cell concentration was determined 
using a Model B Coulter Counter (Coulter Electronics, Inc., Hialeah, 
Florida). Samples of the spleen cell suspension or appropriate dilu­
tions of the spleen cell suspension were mixed in a small tube 
(10 X 75 mm) with 0.05 ml erythrocyte suspension and 0.4 ml of a 0.5 
per cent solution of agarose (Mann Research Laboratories, Inc.,
Orangeburg, New York) in HBSS. The agarose solution had been previously 
melted in the autoclave and was held in a water bath at 48 C. After 
addition of the agarose the contents of the tube were mixed on a vortex 
mixer and poured over the surface of a 1" x 3” glass microscope slide. 
Microscope slides were precoated with a 0.1 per cent solution of agarose 
in d istilled water and were allowed to dry before use. After the ery­
throcyte -spleen cell-agarose mixture had solidified on the microscope 
slide, the slides were inverted on a specially designed tray over a 
solution of HBSS containing 10 per cent guinea pig complement (Colorado
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Serum Co., Denver, Colorado) and a 1:100 dilution of goat anti-mouse 
globulin. The trays were incubated in a humid chamber at 37 C for three 
hours. Indirect plaques were enumerated using a small grid and a 5X 
hand lens with direct ligh t through a blue f i lte r .  The number of plaques 
was expressed as plaque forming cells per 1 x 10^  nucleated spleen cells. 
Each assay was carried out in duplicate. The average number of PFC in 
the duplicate determinations was corrected for background plaques to 
goat erythrocytes as determined by counting the number of PFC on slides 
where spleen cells were plated with control red blood cells.
Determination of Dose of sHGG for Tolerance in Intact Animals 
Groups of 8-9 animals of each of the three strains of mice 
under investigation were injected intraperitoneally with 0.5 mg, 2.5 mg, 
or 12.5 mg sHGG. Ten days later the animals were challenged with an 
intraperitoneal (IP) injection of 0.6 mg aggHGG. The animals received 
a secondary challenge of 0.6 mg aggHGG by the IP route on day 20. Four 
days later they were sacrificed and suspensions of their spleen cells 
assayed for indirect plaque forming cells to HGG. Animals which had 
been treated with saline instead of sHGG served as immunization controls.
Cell Transfer Experiments 
X-irradiation
In order to determine the dose of x-irradiation to use in cell 
transfer experiments, an irradiation death experiment was performed 
with each mouse strain. Animals were subjected to various doses of 
irradiation (350-950 Rads) with a Theratron 80 ^^Cobalt source (Atomic 
Energy of Canada, Ltd.) delivering 145.77 rads per min. The source was
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80 cm from the midline and the fie ld  was 20 cm x 20 cm. After treatment 
the animals were housed three to a cage and were observed daily for 
deaths over a period of th irty  days. The dose which resulted in 60 per 
cent mortality at 30 days was choosen to be used for treatment of re­
cipients in cell transfer experiments.
Preparation of Cells for Transfer 
Mice were sacrificed by decapitation which allowed exsanguina­
tion so that the thymus could be removed free of blood. The thymus was 
removed from the thoracic cavity taking care to detach a ll adjacent 
lymph nodes. Single thymocytes were obtained by pressing a pool of 
donor thymi through a 60 mesh wire screen into cold HBSS which contained 
100 units penicillin and 100 yg streptomycin per ml. HBSS containing 
antibiotics was used as the suspending flu id throughout the transfer 
experiment. The cells were filtered through #80 silk and were washed 
three times in a refrigerated centrifuge. After the final wash the 
thymocytes were resuspended in HBSS and were again filtered through silk 
screen.
Bone marrow cells were obtained by applying hydrostatic pressure 
to the femours and tibiae using a 23 ga needle attached to a syringe 
filled  with HBSS. The cells were dispersed by f irs t  repeatedly flushing 
the bone marrow-balanced salts solution out of a syringe without a 
needle. Further cell dispersion was accomplished by attaching an 18 ga 
needle to the syringe and repeating the flushing process. The bone 
marrow cells were filtered through s ilk  screen and washed three times 
in cold HBSS. The supernatant flu id  of each wash was carefully aspirated 
from the top so that all lipids would be removed during the washing
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process. Cells were resuspended in HBSS and filtered through s ilk  screen 
for a second time to remove any large clumps.
Spleen cells were prepared in a manner similar to that described 
for the localized hemolysis-in-gel assay except that they were not treated 
with ammonium chloride to lyse red blood cells.
Cell concentrations were determined using a Coulter Counter 
(Model B). Any red cells present in the cell suspensions were lysed 
with Zap-Isoton (Coulter Electronics) before the cells were counted.
Determination of Dose of sHGG Required to Render Thymus 
Cells and Bone Marrow Cells Unresponsive
Induction of immunologic unresponsiveness at the thymus cell 
and bone marrow cell levels was evaluated in a manner similar to that 
described by Chiller, Habicht, and Weigle (1970). An outline of the 
experimental protocol appears in Table 1. Donor animals were treated 
with tolerogenic sHGG (0.5 mg, 2.5 mg, or 12.5 mg) or saline by intra­
peritoneal injection. Ten or twenty-two days later the donors were 
sacrificed and suspensions of bone marrow and thymus cells were used to 
reconstitute lethal ly irradiated, syngeneic recipients. Tolerance of 
bone marrow cells was assayed by transferring bone marrow cells from 
tolerant donors together with thymocytes derived from saline treated, 
normal donors. In like manner, transfer of tolerant thymocytes plus 
normal bone marrow cells was used to indicate whether thymus cells had 
become tolerant by the sHGG treatment. Animals reconstituted with nor­
mal thymocytes and normal bone marrow cells served as immunization 
controls.
After preparation of cells as previously described, each
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TABLE 1
EXPERIMENTAL DESIGN FOR DETERMINATION OF BONE MARROW 
AND THYMUS CELL TOLERANCE
Day Treatment Experimental Control
X-i rradi ati on + + +
1 Cell transfer:® Thymus 
Bone Marrow
Normal
Tolerant
Tolerant
Normal
Normal
Normal
AggHGG^ + + +
n AggHGG + + +
16 Jerne plaque assay + + +
Donors of tolerant cells were treated ten or twenty-two days 
previously with 0.5 mg, 2.5 mg, or 12.5 mg soluble human ganma globulin.
^Heat aggregated human gamma globulin.
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irradiated recipient was given an intravenous injection of appropriate 
mixtures of 15 x 10^  bone marrow cells and 45 x 10^  thymus cells. Ani­
mals were reconstituted 4 to 6 hrs after irradiation. Care was taken to 
carry out the entire procedure of cell preparation and transfer within 
3 hrs. On the same day as the cell transfer,each recipient was chal­
lenged intraperitonealy with 0.6 mg aggHGG, and ten days later each ani­
mal was given a similar aggHGG injection. Five days after the secondary 
antigenic challenge, the animals were sacrificed and their spleens 
assayed for indirect PFC to human gamma globulin. Determinations of 
tolerance in thymus cells were made at 10 days after tolerance induction, 
while bone marrow cell unresponsiveness was evaluated at 10 and 22 days 
after sHGG treatment.
Determination of Effect of Tolerant Thymus Cells 
on the Responsiveness of Normal Cells
Lethally irradiated CBF^  male mice were treated with an IV in ­
jection of mixtures of tolerant and normal cells or with mixtures of 
normal cells and cells taken from donors x-irradiated on the day of cell 
transfer. Tolerant donors were treated 10 days previously with 5.0 mg 
sHGG. Experimental groups consisted of animals (10 each) treated with 
a) 45 X 10® normal thymus cells, 45 x 10® tolerant thymus cells, and 
15 X 10® normal bone marrow cells, b) 45 x 10® normal thymus cells, 45 
X 10® irradiated thymus cells, and 15 x 10® normal bone marrow cells, 
and c) 45 x 10® tolerant thymus cells and 15 x 10® normal bone marrow 
cells. The experimental protocol is outlined in Table 2. Normal and 
tolerant thymus cells were administered on the f ir s t  day. The next day 
all animals received an injection of bone marrow cells and an IP
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TABLE 2
EXPERIMENTAL DESIGN FOR ASSAY OF THE EFFECT OF TOLERANT 
THYMUS CELLS ON THE RESPONSIVENESS OF NORMAL CELLS
Day Treatment Experimental
Control
Immune Tolerant
1
X-irradiation + + +
Cell transfer:^ 
Thymus Normal
+
Tolerant
Normal
+
Irradiated
Tolerant
2
Cell transfer: 
Bone marrow Normal Normal Normal
AggHGG^ + + +
12 AggHGG + + +
17 Jerne plaque assay + + +
Donors of tolerant cells were treated ten days previously with
5.0 mg soluble human gamma globulin. X-irradiated thymus cells were 
obtained from donors lethally irradiated (950 R) on the day of sacrifice.
^Heat aggregated human gamma globulin.
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injection of 0.6 mg aggHGG. A secondary challenge with 0.6 mg aggHGG 
was administered 10 days later, and after an additional 5 days animals' 
were assayed for indirect PFC against HGG by the localized hemolysis-in- 
gel test.
Determination of Effect of Tolerant Spleen Cells 
on the Responsiveness of Normal Cells
Spleen cells taken from donors treated 10 days previously with
5.0 mg sHGG were administered to irradiated, syngeneic CBF-j mice to test 
whether these cells would affect the responsiveness of normal cell com­
binations. The experimental groups consisted of irradiated animals 
treated with an IV injection of a) normal thymocytes (45 x 10 )^ and 
tolerant spleen cells (1 x 10^), b) normal thymocytes (45 x 10 )^ and 
normal spleen cells (1 x 10^), c) normal thymocytes (45 x 10 )^ and 
spleen cells i f  irradiated (950 R) donors (1 x 10^), and d) tolerant
O
spleen cells (1 X 10 ). The experimental protocol is presented in 
Table 3. The day following the administration of the above cell com­
binations, all animals were given an IV injection of 15 x 10^  normal 
bone marrow cells. At the same time 0.6 mg aggHGG was administered by 
the IP route. A second IP injection of 0.6 mg aggHGG was given 10 days 
later, and 5 days following this challenge, animals were sacrificed and 
the number of anti-HGG PFC in suspensions of their spleen cells was 
determined.
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TABLE 3
EXPERIMENTAL DESIGN FOR ASSAY OF THE EFFECT OF TOLERANT 
SPLEEN CELLS ON THE RESPONSIVENESS OF NORMAL CELLS
Day Treatment Experimental ControlImmune Tolerant
1
X-irradiation + + + +
Cell transfer:® 
Spleen 
Thymus
Tolerant
Normal
Normal
Normal
Irradiated
Normal
Tolerant
2
Cell transfer: 
Bone marrow Normal Normal Normal Normal
AggHGG*^ + + + +
12 AggHGG + + + +
17 Jerne plaque assa) + + + +
Donors of tolerant cells were treated ten days previously 
with 5.0 mg soluble human gamma globulin. X-irradiated spleen cells 
were obtained from donors lethally irradiated (950 R) on the day of 
sacrifice.
Heat aggregated human gamma globulin.
CHAPTER I I I  
RESULTS
Tolerance Induction in Intact Animals
For detemiination of the susceptibility of BALB/c, C57BL/6,
and CBF-J mice to tolerance induction, groups of animals were treated
with three doses of soluble human gamma globulin (tolerogen), and were
challenged later with 2 injections of heat aggregated HGG (aggHGG).
The animals were assayed by the localized hemolysis-in-gel technique for
indirect plaque forming cells (PFC) to human gamma globulin. The mean
PFC response in each experimental group was used to determine the per
cent suppression according to the following formula:
Mean PFC response of immunization 
controls minus mean PFC response
Per cent _ of experimental group__________  „
suppression " Mean PFC response of immunization
controls
The results of the experiment are shown in Figure 1. BALB/c mice were 
relatively d iff ic u lt to render unresponsive to human gamma globulin. 
Doses of 0.5 mg and 2.5 mg tolerogen resulted in 44 per cent and 23 per 
cent suppression of the anti-HGG PFC response, respectively. However, 
anti-HGG responses of BALB/c mice were suppressed 97.5 per cent by 
treatment with 12.5 mg soluble human gamma globulin (sHGG).
C57BL/6 mice were highly susceptible to tolerance induction 
with sHGG. These animals were 98 per cent unresponsive after treatment
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Figure 1. Per cent suppression o f anti-human gamma globulin plaque forming c e ll response 
of in ta c t animals treated 10 days previously with various doses o f soluble human gamma g lobu lin . 
Number o f immunization controls responding/ to ta l number in  group : BALB/c = 9 /9 , C57BL/6 = 9 /9 ,
CBF-1 = 9 /9 . H orizon ta lly  striped  bars -  BALB/c, dotted bars -  C57BL/6, v e r t ic a l ly  striped bars 
- CBF .^
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with as l i t t le  as 0.5 mg tolerogen. At the higher doses of sHGG (2.5 mg 
and 12.5 mg) C57BL/6 mice were 100 per cent unresponsive.
CBF-| mice, the hybrid of BALB/c and C57BL/6 mice, were similar 
to their C57BL/6 parent in regard to their ease of tolerance induction.
The anti-HGG response in animals treated with 0.5 mg sHGG showed an 
87 per cent suppression of the normal response. Doses of 2.5 mg and
12.5 mg SHGG resulted in 86 and 100 per cent suppression, respectively, 
of the inrnune response to HG6.
Although BALB/c mice could be made tolerant by 12.5 mg soluble 
human gamma globulin, none of the animals were tota lly unresponsive.
All animals in this group had low anti-HGG RFC responses. On the other 
hand, 1 of 8 C57BL/6 and 0 of 8 CBF^ mice had a residual anti-HGG re­
sponse when treated with 12.5 mg sHGG. Seventy-five per cent of C57BL/6 
mice treated with 0.5 mg or 2.5 mg sHGG were s t i l l  responsive. Treat­
ment of CBF^ mice with 0.5 mg tolerogen failed to induce complete sup­
pression in 62.5 per cent of the animals while at the 2.5 mg sHGG dose
37.5 per cent of the animals were responsive.
Determination of Irradiation Dose 
for Cell Transfer Experiments
Groups of mice were exposed to various doses of x-irradiation
ranging from 350 R to 950 R, and the number of animals surviving were
enumerated daily (representative data are found in Tables 4, 5 and 6).
The dose of irradiation which resulted in death of approximately 60 per
cent of the mice th irty  days after treatment was determined by plotting
the percentage of animals surviving at 30 days (LDgoASo) 3^ 93inst the
irradiation dose on a semi-logarithmic scale. This dose was used in
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TABLE 4
SURVIVAL OF BALB/c MICE AFTER EXPOSURE TO VARIOUS 
DOSES OF X-IRRADIATION
Dose (Rads)
Day After Irradiation®
5 10 15 20 25 30
350 9/9 9/9 9/9 9/9 9/9 9/9
450 10/10 10/10 9/10 8/10 8/10 8/10
550 10/10 10/10 8/10 7/10 7/10 6/10
650 10/10 10/10 8/10 3/10 2/10 2/10
750 9/9 9/9 4/9 2/9 1/9 1/9
850 9/9 9/9 1/9 0/9 0/9 0/9
Number of survivors/total number in group.
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TABLE 5
SURVIVAL OF C57BL/6 MICE AFTER EXPOSURE TO VARIOUS 
DOSES OF X-IRRADIATION
Dose (Rads)
Day After Irradiation®
5 10 15 20 25 30
350 6/6 6/6 6/6 6/6 6/6 6/6
450 6/6 6/6 6/6 6/6 6/6 6/6
550 6/6 6/6 5/6 5/6 5/6 5/6
650 9/9 9/9 9/9 9/9 9/9 9/9
750 9/9 7/9 5/9 5/9 4/9 4/9
850 9/9 8/9 7/9 7/9 7/9 7/9
950 8/9 0/9 0/9 0/9 0/9 0/9
Number of survivors/total number in group.
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TABLE 6
SURVIVAL OF CBF, MICE AFTER EXPOSURE TO VARIOUS 
DOSES OF X-IRRADIATION
Dose (Rads)
Day After Irradiation^
5 10 15 20 25 30
650 9/9 9/9 9/9 9/9 9/9 9/9
750 9/9 9/9 9/9 9/9 9/9 9/9
850 9/9 9/9 9/9 8/9 8/9 8/9
950 9/9 8/9 4/9 4/9 4/9 4/9
Number of survivors/total number in group.
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subsequent cell transfer experiments in which recipient animals were 
x-irradiated. The LDgQ/gg dose was chosen to avoid early deaths which 
occur at higher irradiation doses due to destruction of the intestinal 
epithelium. The LDgQ^ o^ BALB/c mice was 600 R. C57BL/6 mice used 
as recipients of transferred cells were irradiated with 750 R, while 
CBF^ mice were treated with 950 R.
Induction of Tolerance in Bone Marrow and Thymus Cells
Ten Days Post Tolerance Induction 
After in vivo exposure of thymus and bone marrow cells to sHGG 
for a period of ten days, these cells were transferred along with the 
appropriate normal cell type (normal thymus cells + tolerant bone marrow 
cells or tolerant thymus cells + normal bone marrow cells) to x-irradiated, 
syngeneic recipients to determine their immune status. Spleen cell sus­
pensions of recipient animals were assayed for anti-HGG RFC following 
two challenges with aggHGG. The per cent suppression caused by sHGG 
treatment was calculated as previously described. Results are listed 
in Figures 2 and 3 and in Table 7.
Thymocytes taken from BALB/c mice which had been injected with 
0.5 mg tolerogen ten days previously were completely responsive (Figure 
2). Thymus cells of BALB/c mice were 14 per cent unresponsive after ex­
posure to 2.5 mg sHGG, whereas 12.5 mg sHGG resulted in a 99 per cent 
suppression of the thymus cell population in the BALB/c mouse strain.
In contrast to results obtained in the BALB/c strain, C57BL/6 
thymocytes were extremely sensitive to tolerance induction. C57BL/6 
thymus cells were suppressed 90 per cent by 0.5 mg sHGG. When 2.5 mg
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Figure 2. Per cent suppression o f anti-human gamma globulin plaque forming c e ll response o f  
irra d ia te d  animals reconstituted with normal bone marrow c e lls  and thymus c e lls  taken from donors 
treated 10 days previously w ith soluble human gamma g lobu lin . Number o f animals reconstituted with  
normal bone marrow and thymus c e lls  responding/ to ta l number in  group: BALB/c = 26 /28 , C57BL/6 = 16/20,
CBFi = 22/24. H orizon ta lly  s triped  bars -  BALB/c, dotted bars -  C57BL/6, v e r t ic a l ly  stripped bars -  
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Figure 3. Per cent suppression of anti-human gamma globulin  plaque forming c e ll response o f 
irra d ia te d  animals reconstituted with normal thymus c e lls  and bone marrow c e lls  taken from donors 
treated  10 days previously with soluble human gamma g lobu lin . Number o f animals reconstituted with  
normal bone marrow and thymus ce lls  responding/ to ta l number in  group: BALB/c = 26 /28 , C57BL/6 = 16/20, 
CBFi = 22/24. H orizon ta lly  striped bars -  BALB/c, dotted bars -  C57BL/6, v e r t ic a lly  striped  bars -  
CBF .^
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TABLE 7
EFFECT OF TREATMENT OF CELL DONORS WITH VARIOUS DOSES OF SOLUBLE 
HUMAN GAMMA GLOBULIN ON THE ABILITY OF THYMUS AND BONE 
MARROW CELLS TO RECONSTITUTE IRRADIATED RECIPIENTS:
A COMPILATION OF THREE EXPERIMENTS
Mouse 
Strai n
Number
of
Animals
Cells
Transferred
Dose
Tolerogen
(mg)
PFC/10Ü
Spleen
Cellsb Range
BALB/c 29 NT-NBM 11.2 0 - 103.0
11 TT-NBM 0.5 16.8 0.4 - 131.4
10 2.5 12.2 0 - 56.0
8 12.5 0.1 0 - 0.5
7 NT-TBM 0.5 4.1 0.3 - 9.0
13 2.5 30.0 0 - 250.0
11 12.5 13.0 0 - 74.0
C57BL/6 20 NT-NBM «. 12.7 0 - 58.8
8 TT-NBM 0.5 1.7 0 - 8.9
8 2.5 5.5 0 - 36.8
7 12.5 0.2 0 - 1.1
12 NT-TBM 0.5 4.9 1 - 12.2
14 2.5 7.3 0 - 20.8
8 12.5 5.9 0 - 17.5
CBF, 24 NT-NBM 11.7 0 - 35.71 9 n-NBM 0.5 2.4 0 - 11.3
11 2.5 0.1 0 - 0.9
9 12.5 0.1 0 - 0.5
12 NT-TBM 0.5 9.5 0 - 27.3
12 2.5 5.0 0 - 28.3
10 12.5 5.7 0 - 30.7
NT - normal thymus cells; TT - tolerant thymus cells;
NBM - normal bone marrow cells; TBM - tolerant bone marrow cells. 
Tolerant donors were treated 10 days previously with soluble human 
gamma globulin.
g N^umber of anti-human ganrna globulin plaque forming cells per 
1 X 10 nucleated spleen cells.
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tolerogen was administered, C57BL/5 thymus cells were 36.6 per cent un­
responsive. I t  is possible that 2.5 mg tolerogen actually suppressed 
C57BL/6 thymus cells to a greater extent than these results indicate as 
one animal in this group had an extremely high PFC response (36.8/ 10^  
spleen cells). The remainder of the group had a mean PFC of 0.8/ 10^  
spleen cells. When the per cent suppression was calculated excluding 
this high responder, thymus cells in the C57BL/6 strain of mice were 
found to be 97 per cent suppressed by 2.5 mg tolerogen. When 12.5 mg 
sHGGwas given, C57BL/6 thymus cells were 98.6 per cent tolerant.
Thymus cells of CBF^ mice became tolerant as easily as did 
those of their C57BL/6 parent. Five tenths milligram of sHGG resulted 
in 90 per cent suppression of this cell population. CBF^ thymocytes were 
98 per cent tolerant after treatment with 2.5 mg sHGG, and at the 12.5 
sHGG dose, CBF^ thymus cells were 100 per cent suppressed.
Tolerance in bone marrow cells after ten days exposure to sHGG 
was more d iff icu lt to accomplish (Figure 3 and Table 7). BALB/c bone 
marrow cells were 55.3 per cent suppressed by 0.5 mg sHGG, however at 
higher doses of tolerogen (2.5 mg and 12.5 mg) no tolerance was detected 
in bone marrow cells from this strain. Bone marrow cells taken from 
C57BL/6 mice were 37 per cent unresponsive at the 0.5 mg sHGG dose.
After treatment with 2.5 mg or 12.5 mg tolerogen, these cells were sup­
pressed 57.7 and 48.6 per cent, respectively. CBF^ bone marrow cells 
were likewise more refractory to tolerance induction than were thymus 
cells. A dose of 0.5 mg sHGG suppressed the responsiveness of these 
cells to 23 per cent, whereas 2.5 mg sHGG resulted in 68 per cent toler­
ance in this cell population. Injection of CBF] mice with 12.5 mg
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tolerogen resulted in bone marrow cells which exhibited 59.5 per cent 
suppression of the ir anti-HGG PFC response.
Bone marrow cells in each of the three strains of mice were 
only rarely, if  ever, completely unresponsive. In those experimental 
groups where some animals were totally unresponsive, comparison of the 
percentage of animals in that group which were responsive to the per­
centage of responsive animals which had been grafted with normal bone 
marrow and thymus cells showed no significant differences. The per­
centage of animals reconstituted with normal thymus cells plus normal 
bone marrow cells which failed to respond could be as high as 20 per 
cent.
Twenty-Two Days Post Tolerance Induction
An experiment was performed to assay suppression of bone marrow 
cell populations of BALB/c, C57BL/6, and CBF^ mice 22 days after injec­
tion of sHGG as Chiller et a l. (1971) had reported that tolerance in 
bone marrow cells of strain A/J mice was not complete until 22 days 
following tolerogen administration. Results of this experiment are 
shown in Figure 4. Twenty-two days after injection of 0.5 mg or 2.5 mg 
sHGG, BALB/c bone marrow cells were 67 and 45 per cent tolerant, re­
spectively. When 12.5 mg tolerogen was administered BALB/c bone marrow 
cells were completely responsive. One animal reconstituted with normal 
thymus cells and normal bone marrow cells responded with 111 PFC per 
10^  spleen cells while the mean PFC response of the rest of the animals 
in the group was 21.5 PFC per 10^  spleen cells. Calculation of the data 
excluding this high responder showed that BALB/c bone marrow cells were 
suppressed 47, 12 and 0 per cent by 0.5 mg, 2.5 mg and 12.5 mg tolerogen.
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Figure 4. Per cent suppression of anti-human gamma globulin plaque forming cell response of 
ir ra d ia te d  animals reco n stitu ted  w ith  normal thymus c e lls  and bone marrow c e lls  taken from donors 
treated 22 days previously with soluble human gamma globulin . Number o f animals reconstituted with 
normal bone marrow and thymus ce lls  responding/ to ta l number in group: BALB/c = 28/28, C57BL/6 = 16/20,
CBF-i = 22/24. Horizontally striped bars - BALB/c, dotted bars - C57BL/6, v e rt ic a lly  striped bars - 
CBR,.
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respectively. Bone marrow cells of C57BL/6 mice were 59 per cent toler­
ant 22 days after administration of 0.5 mg sHGG. Unresponsiveness of
the bone marrow cell population increased to 85 per cent when the ani­
mals were treated with 2.5 mg sHGG. These cells were suppressed 82 per 
cent by 12.5 mg tolerogen. CBF^ bone marrow cells were suppressed 35 
per cent 22 days after injection of 0.5 mg sHGG. Administration of 2.5
mg or 12.5 mg tolerogen resulted in 53 and 60 per cent tolerance, re­
spectively.
As was the case of ne experiment in which bone marrow cells 
were exposed to tolerogen for 10 days, bone marrow cells exposed to sHGG 
for 22 days were hyporesponsive rather than totally unresponsive. How­
ever, the number of responsive animals in experimental groups was not 
significantly different from the number of responsive animals in control 
groups.
These results indicated that bone marrow cells could develop 
a higher degree of unresponsiveness i f  the duration of tolerogen ex­
posure was increased. C:7BL/6 bone marrow cells were rendered unrespon­
sive more easily than were BALB/c bone marrow cells. In fact, tolerance 
comparable to that achieved in the C57BL/6 bone marrow cells could not 
be attained in BALB/c bone marrow cells even at high doses of sHGG. 
Although CBF.J bone marrow cells did not become as unresponsive as did 
those of their C57BI./6 parent, cells from both strains reached their 
maximum degree of unresponsiveness at an sHGG dose of 2.5 mg. I t  could 
be said, therefore, that CBFj bone marrow cells became tolerant in a 
manner similar to that c f their C57BL/6 parent.
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Effect of Sex on Susceptibility of CBF,
Mice to Tolerance Induction
CBF^ mice are the progeny of the mating of a BALB/c female with 
a C57BL/6 male. Because i t  was apparent that the CBFj had inherited 
the high susceptibility to induction of tolerance of its  C57BL/6 father, 
and because male CBFj mice had been used in previous experiments, i t  was 
of interest to determine i f  this tra it  was inherited as a Y-1inked char­
acteristic. Female CBF^ mice were treated with three doses of sHGG, and 
ten days later thymus cells were transferred, along with normal bone 
marrow cells, to x-irradiated CBF-j female recipients. Following two 
challenges with heat aggregated human gamma globulin, the PFC response of 
individual mice was determined, and the per cent suppression calculated. 
For comparative purposes data obtained in separate experiments utilizing 
CBF^ male mice were included with the data from the experiment with CBF^ 
females (Figure 5).
Thymus cells of CBF^ female mice did not become unresponsive 
following treatment with 0.5 mg sHGG, whereas at this same tolerogen dose 
CBF-J male thymus cells were 90 per cent tolerant. When 2.5 mg sHGG was 
administered CBF-j female and CBF-j male thymocytes had reached comparable 
levels of suppression (100 and 98 per cent, respectively). Both male 
and female thymus cells were fu lly  suppressed at the 12.5 mg sHGG dose 
as well. Although tolerance induction was more d iff ic u lt to achieve in 
the CBF-J female than in the male, the female did not inherit the very 
high resistance to tolerance induction characteristic of its  BALB/c 
mother. From these results i t  appeared that the Y-chromosome alone was 
not responsible for inheritance of this very high susceptibility to to l­
erance induction. Apparently the sex of the animal dose have some
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Figure 5. Per cent suppression of anti-human ganrna globulin 
plaque forming cell response of male and female CBP] mice reconstituted 
with normal bone marrow cells and thymus cells taken from donors treated 
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influence on the susceptibility to the production of the unresponsive 
state.
Effect of Tolerant Thymus Cells on the Responsiveness 
of Normal Bone Marrow and Thymus Cells
The report by Gershon and Kondo (1971) that tolerant T-cells 
could suppress the anti-sRBC response of lethally irradiated mice re- 
constit"ted with normal thymus and bone marrow cells suggested that to ler­
ant thymus cells produce a factor which is specifically immunosuppressive. 
I f  this were the case one would expect that C57BL/6 and CBF-j thymus cells 
are more active than BALB/c thymocytes in producing such a factor. To 
test this hypothesis i t  was f ir s t  necessary to determine i f  immunosuppres­
sion of the anti-HGG response of normal cells could be accomplished by 
simultaneous administration of HGG tolerant thymus cells. Mixtures of 
syngeneic tolerant and normal thymus cells were given to CBFj mice. Thy­
mus cells taken from lethally irradiated donors were used in combination 
with normal thymus cells as a control for distribution of cells in the 
lymphoid tissue of the recipient. The following day the animals were 
injected with normal bone marrow cells and a primary challenge of heat 
aggregated human gamma globulin. Following a second aggHGG challenge, 
anti-HGG PFC responses were determined (Table 8). The mean PFC response 
of animals reconstituted with tolerant thymus cells in combination with 
normal thymus cells followed by normal bone marrow cells was lower than 
the PFC response of immunization controls (normal thymus cells plus 
x-irradiated thymus cells). I t  would appear, therefore, that unrespon­
sive thymus cells can suppress the responsiveness of normal cells. How­
ever, due to the small number of animals in experimental groups the
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TABLE 8
EFFECT OF TOLERANT THYMUS CELLS ON THE RESPONSIVENESS 
OF NORMAL BONE MARROW AND THYMUS CELLS
Cells Transferred^
Number of 
Recipients
PFC/10^  . 
Spleen cells Range
NT + XT + NBM 5 7.7 0.7 - 16.2
TT + NT + NBM 8 4.3 1.8 - 5.8
n  + NBM 11 0.6 0 - 3.4
N^T - normal thymus cells; XT - x-irradiated thymus cells;
TT - tolerant thymus cells; NBM - normal bone marrow cells.
g ^Number of anti-human gamma globulin plaque forming cells per 
1 X 10 nucleated spleen cells.
83
suppression observed may not be significant.
Effect of Tolerant Spleen Cells on the Responsiveness 
of Normal Bone Marrow and Thymus Cells
The number of cells in the thymus which are fu lly  mature and
capable of responding to antigenic challenge is relatively small. For 
this reason and because peripheralized immunocompetent cells may have
different properties than those in the thymus, an experiment was per­
formed to test the effect of tolerant spleen cells on the responsiveness 
of normal bone marrow and thymus cells. The experimental protocol was 
similar to that described for the previous experiment except that spleen 
cells were used as the source of tolerant or x-irradiated cells. Re­
sults are shown in Table 9. Animals grafted with tolerant spleen cells 
plus normal thymus and bone marrow cells had a mean PFC response (3.4 
per 10^  apleen cells) which was less than that detected in animals re­
constituted with x-irradiated spleen cells plus normal thymus and bone 
marrow cells (4.8 per 10^  spleen cells). However, this depression does 
not appear to be significant.
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TABLE 9
EFFECT OF TOLERANT SPLEEN CELLS ON THE RESPONSIVENESS 
OF NORMAL BONE MARROW AND THYMUS CELLS
Cells Transferred^
Number of 
Recipients
PFC/IOG . 
Spleen Cells Range
NS + NT + NBM 10 30 9.6 - 120.0
TS + NBM 6 1 0 - 4.1
XS + NT + NBM 9 4.8 0 - 11.9
TS + NT + NBM 9 3.4 2.0 - 8.9
NT - normal thymus cells; NS - normal spleen cells;
TS - tolerant spleen cells; XS - X-irradiated spleen cells; NBM - normal 
bone marrow cells.
g *^ Number of anti-human gamma globulin plaque forming cells per 
1 X 10 nucleated spleen cells.
CHAPTER IV 
DISCUSSION
This investigation was undertaken to determine i f  differences 
in the susceptibility to induction of tolerance in inbred mouse strains 
could be attributed to varying sensitivity to tolerance induction of 
thymus cells and/or bone marrow cells. Three mouse strains, BALB/c, 
C57BL/6, and the F-j hybrid of a cross-mating of these two strains (CBF^ ), 
were tested for unresponsiveness following injection of deaggregated 
human gamma globulin (sHGG). These mouse strains were chosen because 
i t  had been previously reported (Golub and Wiegie, 1969) that there was 
a marked difference in the susceptibility of BALB/c mice and C57BL/6 
mice to induction of the unresponsive state with human gamma globulin, 
and that the F^  hybrid of these two mouse strains had inherited the 
characteristic high sensitivity to induction of tolerance exhibited by 
its  C57BL/6 parent. The results of the present investigation revealed 
that C57BL/6 and CBF] mice became tolerant with doses of sHGG as low as 
0.5 mg. BALB/c mice were not tolerant unless they were treated with
12.5 mg tolerogen. These results agreed with those of Golub and Weigle 
that C57BL/6 mice were more sensitive to the production of the unrespon­
sive state than were BALB/c mice and that the F.j hybrid of these two 
mouse strains had inherited the sensitivity to tolerance induction of 
its  C57BL/6 parent. Golub and Weigle were unable to induce
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unresponsiveness in BALB/c mice at any tolerogen dose tested ranging as 
high as 10 mg. Discrepancies between their results and the observations 
reported here might be explained by variations in experimental protocol. 
Tolerogen preparations used in this investigation were centrifuged for
2.5 hrs at 100,000 X g, while Golub and Weigle prepared tolerogenic pro­
tein solutions by centrifugation at 20,000 X g for 30 min. Centrifugation 
at higher speed and for a longer period of time may have resulted in more 
efficient removal of aggregated material from the protein solutions. The 
Jerne plaque assay used in this investigation is a quantitative one which 
allows delineation of the degree of unresponsiveness induced in tolerogen 
treated animals. Golub and Weigle used the qualitative, immune elimina­
tion test to score animals as responsive or unresponsive. In the immune 
elimination procedure, an animal having a significant suppression of the 
PFC response might produce an amount of antibody sufficient to clear 
radiolabeled antigen and thus be scored as responsive. Because the 
BALB/c mice treated with 12.5 mg sHGG, although significantly suppressed, 
were found to be hyporesponsive, i t  is possible that by immune elimina­
tion they would have been considered as responsive.
Golub and Weigle suggested that differences in the susceptibi­
l i ty  to tolerance induction of BALB/c and C57BL/6 mice might be a t t r i­
buted to the difference in the efficiency with which these mouse strains 
process trace amounts of aggregated material in tolerogen preparations 
for a subsequent immune response. This conclusion was based on the 
observation that their centrifuged tolerogen preparations contained 
aggregated material when i t  was subjected to analytical ultracentrifuga­
tion. They also noted that BALB/c mice could be rendered unresponsive
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with lower doses of tolerogenic material which had been prepared by a 
sodium sulfate fractionation procedure. The sodium sulfate fractionated 
material did not contain aggregated material as judged by analytical 
ultracentrifugation. Hyde and Weigle (unpublished observations) found 
that phagocytes of BALB/c and C57BL/6 mice did not differ in their rates 
of engulfment of aggregated HGG nor did they d iffe r in their ab ility  to 
ingest antigen during tolerance induction. In addition, macrophages 
taken from tolerant animals were fu lly  capable of participating in an 
immune response to the tolerated antigen. Neill, Cole and Hyde (1972) 
reported that C57BL/6 mice could clear intravenously injected carbon 
more efficiently than BALB/c mice. Because BALB/c and C57BL/6 mice 
apparently have phagocytes which are not functionally different, i t  was 
postulated that differences in susceptibility to tolerance induction of 
thymus cells and/or bone marrow cells may account for the differing 
sensitivities of these mouse strains to induction of the unresponsive 
state.
Experiments undertaken to determine the sensitivity of thymus 
cells and bone marrow cells to tolerance induction revealed that ten 
days after tolerogen administration C57BL/6 and CBF-j thymus cells were 
significantly suppressed by the entire range of sHGG doses employed 
(0.5 mg to 12.5 mg). On the other hand, BALB/c thymus cells did not 
develop a high degree of tolerance until the animals were treated with
12.5 mg sHGG. The establishment of unresponsiveness in bone marrow cells 
was less easily achieved than was tolerance induction in thymocytes.
After ten days exposure to tolerogen C57BL/6 and GBFj bone marrow cells 
had reached their maximum degree of suppression when treated with 2.5 mg
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tolerogenic HGG. C57BL/6 bone marrow cells were 57.7 per cent unrespon­
sive and CBRj bone marrow cells were suppressed 68 per cent by 2.5 mg 
sHGG. BALB/c bone marrow cells were 37 per cent tolerant when animals 
were treated with 0.5 mg sHGG, however at higher tolerogen doses unre­
sponsiveness could not be detected in BALB/c bone marrow cells. Even 
though bone marrow cells of all three mouse strains were more refractory 
to tolerance induction than were thymus cells, i t  appeared that tolerance 
induction in bone marrow cells of CBF^ and C57BL/6 mice followed a 
similar pattern; i.e . ,  in both mouse strains maximum suppression of bone 
marrow cells occurred at comparable tolerogen doses. Results obtained 
by assaying bone marrow cell tolerance after 22 days exposure to tolero­
gen confirmed this observation. At this time period both CBF-j bone 
marrow cells and C57BL/6 bone marrow cells were suppressed to the great­
est extent at the 2.5 mg sHGG dose (63 and 85 per cent respectively).
At the higher (12.5 mg) dose bone marrow from C57BL/6 and CBF^ mice were 
only slightly less tolerant. I t  could be that differences in the degree 
of unresponsiveness observed between CBF^ and C57BL/6 bone marrow cells 
reflect differences in the kinetics of tolerance induction in bone mar­
row cells in these two mouse strains. Chiller, Habicht and Weigle (1971) 
in studies of the kinetics of tolerance induction in bone marrow cells 
obtained 100 per cent suppression 21 days after tolerogen administration. 
However, complete tolerance was only observed at this one assay date.
At other time periods between 8 and 42 days after injection of deaggreg­
ated HGG, bone marrow cells were found to be 60 to 80 per cent tolerant. 
Unresponsiveness in BALB/c bone marrow cells exposed to tolerogen for 
22 days was inversely related to the dose of sHGG administered.
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Nevertheless, even the maximum degree of unresponsiveness (67 per cent) 
observed in the bone marrow cells of BALB/c mice treated with 0.5 mg 
tolerogen did not exceed the suppression obtained in C57BL/6 and CBF^ 
mice at higher doses. Suppression of BALB/c bone marrow cells by low 
but not high tolerogen doses might be accounted for by the fact that as 
the protein concentration of the tolerogen preparation increased the 
chance for contamination with aggregated gamma globulin increased as 
well. Kawaguchi (1970) reported that simultaneous injection of soluble 
bovine gamma globulin (sBGG) and aggregated bovine gamma globulin 
(aggBGG) interfered with the tolerogenic properties of sBGG. A concen­
tration of aggBGG which was 1 per cent of the sBGG dose was effective 
in preventing the induction of the unresponsive state. Gershon and 
Kondo (1970) reported that some mouse bone marrow cells did not require 
T-cell helper activity in the anti-sRBC response. I f  this is the case 
in the anti-HGG response, one could postulate that such cells were 
primed by contaminating aggregated material in tolerogen preparations. 
Observations of tolerance induction in the bone marrow cell populations 
of these three mouse strains confirmed the observation of Chiller, 
Habicht and Weigle (1971) and Weigle, Chiller and Habicht (1972) that 
tolerance induction in these cells required a higher dose of tolero­
genic material and a longer induction period than was necessary for the 
establishment.of an unresponsive state in thymus cells.
Comparison of the levels of unresponsiveness attained in either 
thymus or bone marrow cells with those observed in intact animals at 
various sHGG doses revealed that, for all three mouse strains tested, 
whole body tolerance was reflected in the susceptibility of thymocytes
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to the induction of tolerance. Similar results were reported by Chiller, 
Habicht, and Weigle (1971) who found tolerance in the A/J mouse strain 
to be a function of the sensitivity of thymus cells to the induction of 
the unresponsive state. The present investigation has shown, further 
that bone marrow cells from mouse strains which are highly susceptible 
to tolerance induction are likewise more sensitive to tolerogen treatment 
than are bone marrow cells from a mouse strain which is more refractory 
to induction of unresponsiveness.
The mechanism of the production of the tolerant state upon the 
interaction of antigen with immunocompetent cells is not known. Alter­
native views state that in the unresponsive animal there may be a de­
struction of cells capable of responding to the tolerated antigen, that 
clones of cells may be specifically paralysed but s t i l l  be living, or 
that enhancing antibody blocks the immunologie potential of immunocom­
petent cell clones.
Studies of the kinetics of induction of and escape from tolerance 
might provide a clue to the mechanism of the unresponsive state. A 
rapid inactivation of cells implies that there has been a direct inter­
action of antigen with cell surface receptors resulting in paralysis or 
death of the cells. On the other hand, a prolonged period for tolerance 
induction would suggest that some active process is involved in the 
production of the unresponsive state. The observation of Chiller,
Habicht and Weigle (1971) that ther? is a distinct difference in the 
kinetic pattern of induction of and escape from immune tolerance between 
T and B lymphocytes may mean that different mechanisms of induction are 
operable in each of these two cell populations. Rapid inactivation of
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thymie lymphocytes within the f ir s t  twenty four hrs after tolerogen ad­
ministration suggests that these cells are killed or inactivated upon 
direct interaction of antigen with receptor sites on the T-cell membrane. 
Differences in the sensitivity of thymus-dependent cells of BALB/c, 
C57BL/6 and CBF^ mice to tolerance induction might then be attributed to 
differences in the avidity or concentration of receptor sites on these 
cells. More efficient binding of tolerogen by C57BL/6 and CBF^ thymo­
cytes could result in a greater inactivation or elimination of clones 
of cells reactive to that antigen. Alternatively, these cells may re­
quire fewer hits with tolerogenic antigen for the subsequent production 
of the unresponsive state. Inactivation or death of thymus-dependent 
lymphocytes in tolerant animals may in itse lf explain why C57BL/6 and 
CBF| bone marrow cells became tolerant more easily than did BALB/c bone 
marrow cells. Because the end result of antigen exposure may reflect 
the outcome of competition between tolerogenic and immunogenic forms of 
the same antigen, any event which eliminates helper activity for immuni­
zation may increase the tolerogenic potential of the injected material. 
Due to the fact that CBF^ and C57BL/6 thymus cells become tolerant at 
low antigen doses, one might expect a lower threshold for tolerance in­
duction in the bone marrow cell population of these two mouse strains due 
to elimination of T-cell helper activity. I t  would be interesting to 
know i f  tolerance can be induced to HGG in bone marrow cells in neona­
tal ly thymectomized or irradiated, thymectomized, bone marrow repopulated 
mice, and i f  in such animals, strain variation such as that observed in 
this investigation occurs. The observation of Chiller, Habicht and 
Weigle that there is a delay in the production of the unresponsive
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state in bone marrow cells of about one week following administration 
of deaggregated HGG suggests that some sort of active process must occur 
before tolerance can occur in this population of cells. Gershon and 
Kondo (1970) reported that bone marrow-derived lymphocytes which depend 
upon the interaction of antigen with T-cells before they are triggered 
for antibody production also require the presence of thymus cells to 
be rendered specifically unresponsive to the sRBC antigen. These 
workers (Gershon and Kondo, 1971) found that adoptive transfer of spleen 
cells from mice which were tolerant to sRBC would specifically prevent 
cooperation of normal thymocytes and normal bone marrow cells. They 
suggested three mechanisms whereby such an immunosuppressive effect by 
tolerant cells might be obtained; f irs t ,  free antigen may be transferred 
along with the tolerant cells; second, the effect may be due to a pro­
duct of tolerant bone marrow-derived cells; or third, the effect may be 
due to a product of tolerant thymus-derived cells. They ruled out the 
possibility that they were transferring antigen in their spleen cell 
preparations since spleen cells of thymus-deprived mice treated with 
to ierizing regimen of sRBC did not produce adoptive tolerance. Although 
i t  is known that antibodies can interfere with the immune response, 
Gershon and Kondo believed that passively administered antibody was not 
operable in their experiments. They obtained suppression when spleen 
cells of donor mice were not producing antibody and when there was no 
detectable serum antibody in donor animals. Spleen cells from animals 
which were producing antibody did not cause immunosuppression. Because 
high affin ity antibodies are better able to interfere with antibody pro­
duction, i t  seemed unlikely that the small amount of unmeasurable
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antibody which may be present in the tolerant animal could be causing 
this effect in ligh t of observations that partia lly tolerant animals 
produce antibody of low affin ity . By a process of elimination of other 
mechanisms, these authors proposed that immunosuppression occurred due 
to a product of thymus-derived lymphocytes. They suggested that toler­
ant thymus cells produce an antigen-specific, immunosuppressive substance 
which they named IgY. The fact that several different investigators 
have been unable to abrogate the tolerant state by adoptive transfer of 
normal, syngeneic lymphocytes into tolerant animals lends support to 
this hypothesis (Crowle and Hu, 1959; Tong and Boose, 1970; McCullagh, 
1970a; Chiller and Weigle, 1972). In addition McCullagh (1970a) reported 
that tolerance was induced in the transferred normal spleen cell popula­
tion within three days residence in the tolerant host. Tong and Boose 
(1970) found that immunized spleen cells could not break tolerance in 
the unresponsive animal, thus i t  seemed unlikely that residual tolero­
genic material could account for the unresponsiveness produced in the 
transferred cell population. Another observation favoring the hypothesis 
that residual tolerogen was not the factor which had rendered normal 
cells unresponsive was the report by McGregor, McCullagh and Gowans 
(1967) that normal cells w ill restore immunocompetence to x-irradiated, 
tolerant animals. In addition, Tong and Boose (1970) found that serum 
from tolerant mice caused a significant inhibition of the immune re­
sponse of normal mice. However, spleen cells from these same tolerant 
donors did not inh ib it the immune response after transfer to normal 
mice. I f  tolerant thymus cells produce an immunosuppressive factor, such 
as the IgY postulated by Gershon and Kondo, one would expect that thymus
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cells of CBF^ and C57BL/6 mice are more active producers of this sub­
stance or that they are triggered more easily to elaborate this material. 
Experiments employing transfer of mixtures of tolerant and normal cells 
provided suggestive evidence that tolerant thymus and,to a lesser degree, 
tolerant spleen cells could interfere with the responsiveness of normal 
thymus and bone marrow cells. I t  should be noted, however, that our ex­
perimental design was quite different from the elaborate double transfer 
system used by Gershon and Kondo (1971). For this reason direct compari­
son of their results with the results reported here may not be valid.
The conclusion that T-cells do or do not produce an immunosuppressive 
substance must,therefore, await more exhaustive experimentation.
That the mechanism of tolerance induction in T-cells and B-cells 
may be different has been borne out in studies of tolerance to the 
thymus-independent antigen pneumococcal polysaccharide (SSS) (Howard, 
1972). Inmune tolerance induction with SSS was found by Siskind and 
Howard (1966) and by Matangkasombut and Seastone (1968) to be preceded 
by a phase of weak immunity. Such an immune phase has not been found 
during induction of tolerance in mice to thymus dependent antigen 
(Chiller and Weigle, 1971). Howard (1972) suggested that,even though 
this phenomenon might be attributed to the prolonged period required 
for tolerance in bone marrow cells, there were reasons to believe that 
the evanescent period of antibody production was related to subsequent 
induction of unresponsiveness to pneumococcal polysaccharide. The in­
verse relationship between molecular size of antigen and its  tolerogenic 
properties which exists with thumus-dependent antigens does not hold 
true for pneumococcal polysaccharide. Howard, Zola and Courtenay (1971)
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found that as SSS was broken down into small fragments by heating aqueus 
solutions of the material under pressure, i t  lost its  immunogenic pro­
perties as well as its  tolerogenic potential. Antigen which remains in 
SSS tolerant mice is fu lly  able to induce immunity in normal mice (Howard 
and Siskind, 1969; Howard et a l. 1970) in contrast to results which show 
that protein antigens in the blood of tolerant animals are tolerogenic 
(Frei et a l. 1965; Golub and Weigle, 1969). I t  has been reported that 
animals primed with thymus-dependent antigens have an increased threshold 
to induction of the unresponsive state with the priming antigen (Cerny 
and Ivanyi, 1966). On the other hand, animals primed with SSS show mini­
mal changes in their threshold to tolerance induction. Howard (1972) 
suggested that the time required to induce tolerance in bone marrow cells 
is excessive i f  one assumes that determinant-receptor interaction is the 
sole requirement, and that such a delayed onset of tolerance in this cell 
population suggests that antibody formation is a mandatory step for bone 
marrow cell tolerance. Studies of tolerance induction with SSS in 
strains of mice which vary in the development of an unresponsive state 
to this antigen might shed further light on the mechanism of tolerance 
induction in bone marrow-derived cells since this antigen eliminates 
confusion caused by concomitant tolerance induction in thymus-derived 
cells. Such studies may help elucidate any mechanistic differences 
which might occur during induction of tolerance with thymus-dependent 
and thymus-independent antigens.
In vitro studies by Feldmann and coworkers (Diener and Feldmann, 
1972) on the induction of tolerance have helped determine the possible 
mechanism of tolerance in bone marrow-derived lymphocytes. These
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investigators utilized the flagellar antigens of Salmonella adelaide 
which are available in three different forms: polymerized flagellin 
(POL, m.w. n x 40,000), monomeric flagellin  (MON, m.w. 40,000) and a 
cyanogen bromide digest of flagellin , fragment A (m.w. 18,000). The 
polymerized form of this antigen was shown by Diener, O'Callaghan and 
Kraft (1971) to be thymus-independent, and for this reason, i t  allows 
investigation of tolerance at the B-cell level. As was found during 
in vivo studies with SSS, in vitro immunogenicity of these various 
flagellin preparations was directly related to their molecular weight 
(Diener and Feldmann, 1970) and in v itro , POL, the most immunogenic of 
these three antigens, was also the most tolerogenic. Preincubation of 
spleen cells with supraimmunogenic concentrations of POL followed by 
washing and 4 d?ys incubation in the presence of immunogenic concentra­
tions of POL resulted in unresponsiveness. Fragment A which was found 
to be a potent tolerogen in vivo by Ada and Parish (1968) failed to in­
duce tolerance in v itro . Diener and Feldmann also failed to obtain low 
zone tolerance in vitro using these antigens, although they are known to 
produce such an effect in vivo. Thus, i t  was apparent that some mechan­
ism which was operable in producing low zone tolerance and tolerance to 
fragment A was missing under in vitro conditions.
Further insight into the structural requirements for tolerogenic 
antigen in vitro came from the work of Feldmann (1972a). He observed 
that only DNP-POL could induce tolerance to the DNP hapten in v itro . 
DNP-HGG, DNP-BSA and DNP-MON were not tolerogenic. Feldmann noted, in 
addition, that tolerance to DNP only occurred when there was a large 
number of DNP residues conjugated to POL. The requirement for a high
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hapten density suggested that induction of tolerance required formation 
of many closely spaced bonds with receptors on the surface of the 
immunocompetent cell.
In order to explain the potent tolerogenic activity of fragment 
A in vivo, Diener and Feldmann suggested that the additional mechanism 
provided by the intact animal may cause interlinking between monomeric 
antigen units. A highly like ly candidate for such interlinking activity 
was specific antibody. These workers (Feldmann and Diener, 1970) re­
ported that at a critica l ratio of antigen to antibody in vitro suppres­
sion of antibody formation could be obtained with low antigen concentra­
tion. The immune suppression was due to a central effect and was en­
tire ly  different from the immunosuppressive activity produced by excess 
antibody which prevents induction of tolerance while suppressing immune 
induction. Feldmann and Diener (1972) reported that only divalent anti­
body was effective in producing antibody-POL mediated immune suppression. 
In addition, fragment A, which was not tolerogenic by its e lf in v itro , 
when in combination with the appropriate concentration of specific anti­
body, produced unresponsiveness in v itro .
Successful antibody mediated tolerance induction in vitro with 
fragment A suggested the possibility that such a system may work with 
other antigens, such as BSA, where in vitro attempts at producing toler­
ance have been unsuccessful, whereas such antigens are effic ient tolero- 
gens in vivo. Diener and Feldmann (1972) were able to induce tolerance to 
ultrasonically fragmented sRBC provided that specific antibody was pre­
sent at defined concentrations. Likewise, Diener and Feldmann (1972) 
have obtained antibody-mediated tolerance using chicken gairnia globulin
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as antigen. Since they could demonstrate anti gen-antibody mediated toler­
ance with a variety of antigens, these workers concluded that i t  was a 
general immunologic phenomenon and was not restricted to Salmonella 
flagellar antigens. Two reasons were set forth by Diener and Feldmann 
to support the contention that in v itro , antibody-mediated, low zone 
tolerance is similar to that observed in vivo. First, concentrations of 
antigen necessary for the induction of in vivo and in vitro low zone 
tolerance are similar and second, the lag period required to e lic it  low 
zone tolerance is most easily explained by the necessity for antibody 
production prior to induction of the unresponsive state. These investi­
gators have postulated that when the number of antigen-recognition sites 
cross-linked by antigen exceeds a critica l threshold tolerance ensues. 
Cross-linking below this critica l threshold level induces immunity.
Diener and Feldmann believe that monomeric antigen complexed with anti­
body can serve as a la ttice of repeating determinants in the same manner 
as polymeric forms of the same antigen.
I f  similar mechanisms apply to tolerance induction in bone 
marrow-derived cells by protein antigens such as HGG and thymus-inde­
pendent antigens such as POL, several alternative hypothesis may be pro­
posed to account for differences in susceptibility of bone marrow cells 
from different mouse strains to tolerance induction: 1) bone marrow 
cells may have antigen recognition sites of varying avidities; 2) the 
critica l number of receptors which must be cross-linked to produce the 
tolerance "signal" may vary among strains of mice; 3) bone marrow cells 
from different mouse strains may have different membrane densities 
of antigen receptors; or 4) the amount of antibody produced by certain
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strains of mice upon interaction with tolerogen may reach the critical 
concentration needed for antibody-mediated tolerance, while in other 
strains of mice there may be too much or too l i t t le  antibody present for 
such immune suppression to occur. Further investigations of tolerance 
induction in BALB/c, C57BL/6 and CBFj mice may provide some clue as to 
the nature of the unresponsive state in bone marrow and bone marrow- 
derived cells. While the lag noted during the induction of bone marrow 
cell tolerance in mice suggests that antibody mediated suppression may 
occur in this cell population, i t  should be pointed out that periphera- 
lized bone marrow-derived cells may exhibit a kinetic pattern of induc­
tion of the unresponsive state different from that of cells within the 
bone marrow. Chiller and Weigle (1972) presented data which suggested 
that peripheralized B-cells become tolerant within three days of injec­
tion of deaggregated human gamma globulin. Such results reveal the need 
for detailed investigations of tolerance induction in lymphocytes resi­
dent in both central and peripheral lymphoid tissue, as well as delinea­
tion of the effect of the presence or absence of one cell type during 
induction of tolerance in cells of the opposite type.
The fact that tolerance can be induced in CBF^ mice as easily 
as in their C57BL/6 parent suggests that ease of tolerance induction is 
a dominant characteristic. These data may seem to f i t  a phenomenon 
which could be related to the inheritance of a single gene. However, 
Golub and Weigle (1969) in preliminary investigations of the Fg and 
backcross mice of these same mouse strains ruled out the possibility 
that such inheritance was controlled by a single gene. Indeed, the 
differences observed in the induction of the unresponsive state in male
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and female CBF^ mice In this investigation suggests that the production 
of unresponsiveness may depend on the balance between many factors. 
Nevertheless, apparent dominance of the tra it ,  whether i t  be due to one 
gene or several genes, implies that the mechanism of the induction of 
tolerance is a positive event.
CHAPTER V 
SUMMARY
A comparative study of three mouse strains which vary in their 
susceptibility to induction of immune tolerance with human gamma globulin 
was undertaken to evaluate the cellular basis for the differing sensiti­
vities of these strains to the induction of the unresponsive state.
BALB/c mice became tolerant only when treated with 12.5 mg of a highly 
tolerogenic, ultracentrifuged preparation of human gamma globulin (sHGG). 
C57BL/6 and CBF^ (BALB/c x C57BL/6) mice were significantly suppressed 
by doses of sHGG as low as 0.5 mg. Tolerance observed in intact animals 
of all three mouse strains was reflected in the sensitivity of thymus 
cells to the induction of unresponsiveness. Bone marrow cells from each 
of the mouse strains were more resistant to the production of tolerance 
than were thymus cells. Bone marrow cells assayed after 22 days of ex­
posure to sHGG exhibited a higher degree of suppression than when they 
were assayed 10 days following administration of sHGG. Bone marrow cells 
of C57BL/6 and CBF^ mice were suppressed to a greater extent than were 
similar cells taken from BALB/c mice. In addition, maximum suppression 
of C57BL/6 and CBF^ bone marrow cells occurred at the same dose of 
tolerogen (2.5 mg). I t  was concluded that CBF-j mice inherited the sensi­
t iv ity  to tolerance induction exhibited by thymus cells and by bone 
marrow cells of their C57BL/6 parent. When x-irradiated recipients were
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grafted with tolerant thymus or tolerant spleen cells in combination 
with normal thymus and normal bone marrow cells, a slightly reduced 
number of plaque forming cells was observed as compared to controls.
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